data_6afq_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6afq _Structure_validation_residue.Date_analyzed 2019-08-09 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.149 0 CA-C-O 120.773 0.239 . . . . 74.35 112.365 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 pt -113.49 123.91 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 74.15 111.109 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.516 ' HB ' ' CG ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -137.13 136.51 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 71.32 111.138 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.489 ' HD1' ' CE1' ' A' ' 21' ' ' PHE . 2.7 p90 -114.98 150.67 35.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.207 -0.451 . . . . 74.43 110.943 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.8 t -146.28 130.14 17.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 73.1 110.881 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -106.47 87.31 2.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 75.52 110.909 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -57.6 -16.52 10.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.857 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -69.74 -30.7 68.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 73.41 110.88 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 t -130.92 8.72 4.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 74.32 111.117 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.32 70.49 0.93 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.744 -0.741 . . . . 60.24 112.5 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -155.21 116.63 4.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 74.13 110.915 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.97 170.91 12.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 71.45 110.851 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.55 156.52 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 73.42 110.9 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.516 ' CG ' ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -106.45 140.68 38.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 74.54 110.868 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.489 ' CE1' ' HD1' ' A' ' 10' ' ' TYR . 3.1 m-85 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 74.32 110.88 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.231 0.156 0 CA-C-O 120.737 0.224 . . . . 72.35 112.376 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.7 pt -113.58 123.34 69.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 74.12 111.089 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.13 140.01 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 75.32 111.142 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -113.96 150.82 33.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.892 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.7 t -148.31 123.56 10.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 70.01 110.907 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -115.82 85.79 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 75.4 110.867 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 -61.18 -15.05 29.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 73.54 110.862 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -71.79 -32.23 67.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 65.02 110.887 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.9 t -123.81 7.51 8.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 73.35 111.137 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.74 67.18 2.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 53.04 112.498 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -154.69 115.31 3.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.338 . . . . 75.23 110.9 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.89 162.75 32.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 54.14 110.873 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.481 ' O ' HD13 ' A' ' 9' ' ' ILE . 0.3 OUTLIER 178.98 157.87 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 73.22 110.949 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -116.57 129.22 56.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 73.31 110.902 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.605 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 75.44 110.898 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.148 0 CA-C-O 120.797 0.249 . . . . 73.31 112.317 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 pt -113.64 123.13 68.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 74.23 111.115 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.67 141.08 35.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 71.22 111.119 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -114.25 150.09 34.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 63.45 110.925 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 t -149.25 120.65 7.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 62.44 110.878 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -114.41 88.31 2.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.477 . . . . 74.52 110.851 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -58.58 -17.82 24.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 74.33 110.846 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -76.26 -56.07 4.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 74.35 110.86 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.5 t -92.18 8.93 35.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 73.31 111.161 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.06 68.34 1.45 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.76 -0.733 . . . . 52.52 112.524 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -155.18 116.57 4.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.796 0.331 . . . . 74.02 110.938 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.5 m -136.03 157.06 47.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 62.32 110.846 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.474 ' O ' HD12 ' A' ' 9' ' ' ILE . 1.7 tt0 178.36 158.57 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 75.3 110.932 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -117.61 129.52 55.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.12 110.842 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.597 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 75.24 110.933 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.81 0.254 . . . . 74.55 112.345 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 pt -113.64 123.12 68.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 64.42 111.088 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.65 141.05 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.472 . . . . 73.34 111.135 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -114.23 150.12 34.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 74.45 110.914 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.3 t -149.32 120.49 7.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 75.2 110.893 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -114.26 88.26 2.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 75.33 110.878 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -58.59 -17.8 24.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 73.43 110.859 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -76.15 -55.89 5.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 73.43 110.84 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.5 t -92.53 8.98 36.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 64.43 111.135 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.12 68.36 1.45 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 62.1 112.468 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -155.29 116.59 3.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 75.34 110.918 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.3 m -136.02 157.13 47.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 74.51 110.867 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.479 ' O ' HD12 ' A' ' 9' ' ' ILE . 4.0 tt0 178.38 158.49 0.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 75.5 110.951 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.59 129.51 55.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 75.14 110.894 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.606 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 61.04 110.908 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.194 0 CA-C-O 120.752 0.23 . . . . 74.23 112.396 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 pt -113.63 123.23 69.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.44 . . . . 64.24 111.134 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -139.56 142.03 33.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 74.45 111.14 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -113.84 149.8 34.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 72.51 110.887 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.82 116.95 6.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 72.42 110.898 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -117.65 86.78 2.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.867 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.0 ptt85 -60.57 -16.05 33.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 74.42 110.9 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -71.97 -56.33 5.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 75.23 110.855 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.8 t -96.88 10.25 39.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 72.13 111.133 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.79 72.34 0.56 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.736 -0.745 . . . . 70.2 112.502 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -154.37 114.54 3.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.819 0.342 . . . . 75.41 110.868 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.4 t -135.33 152.65 51.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 73.12 110.899 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.479 ' O ' HD12 ' A' ' 9' ' ' ILE . 3.2 tt0 175.84 159.51 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 74.24 110.89 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -119.21 129.41 54.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 74.24 110.901 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.599 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 75.44 110.901 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.768 0.237 . . . . 74.12 112.308 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.7 pt -113.49 123.33 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 75.33 111.153 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.1 140.2 38.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 73.2 111.11 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -114.18 150.81 33.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 74.43 110.952 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.7 t -148.41 125.02 11.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 63.35 110.861 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -116.23 87.12 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 73.41 110.919 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -15.79 29.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 74.11 110.895 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -44.63 66.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 75.12 110.871 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 t -110.27 8.53 23.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 74.1 111.163 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.79 70.24 1.02 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.737 . . . . 61.25 112.497 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 9.7 ptmt -159.34 119.91 3.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 74.41 110.879 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.58 165.19 27.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 74.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.482 ' O ' HD13 ' A' ' 9' ' ' ILE . 1.3 tt0 178.65 157.94 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 74.34 110.93 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.522 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.06 129.42 55.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 75.35 110.837 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.599 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 74.51 110.857 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.769 0.237 . . . . 75.34 112.35 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.7 pt -113.62 123.33 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 74.14 111.126 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.07 140.19 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 74.34 111.103 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -114.21 150.81 33.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 71.23 110.882 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.6 t -148.33 125.0 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 65.03 110.913 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -116.3 87.14 2.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 73.31 110.859 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -60.49 -15.71 29.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 74.21 110.881 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -70.6 -44.22 67.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 75.54 110.862 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 t -110.76 8.42 22.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 75.22 111.143 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.94 70.12 1.06 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.772 -0.727 . . . . 74.4 112.487 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 12.1 ptmt -159.25 119.87 3.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 74.2 110.909 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.59 165.23 27.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 73.21 110.86 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.48 ' O ' HD13 ' A' ' 9' ' ' ILE . 4.2 tt0 178.63 157.96 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 70.44 110.923 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.06 129.45 56.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 74.34 110.891 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.607 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.859 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.156 0 CA-C-O 120.767 0.236 . . . . 70.33 112.323 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 pt -113.57 123.28 69.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 74.34 111.151 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.13 140.27 38.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 72.32 111.147 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -114.2 150.76 33.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 72.45 110.909 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.7 t -148.4 124.98 11.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 73.31 110.894 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -116.35 87.06 2.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 72.41 110.882 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.34 -15.85 29.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 75.53 110.856 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.5 -45.21 66.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 75.35 110.836 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 t -109.63 8.39 24.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 74.23 111.098 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.9 71.02 0.79 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.798 -0.715 . . . . 42.45 112.476 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 42.0 pttt -160.29 120.21 2.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 72.43 110.878 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.76 165.1 27.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 74.15 110.868 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.486 ' O ' HD12 ' A' ' 9' ' ' ILE . 0.3 OUTLIER 178.76 158.04 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 75.2 110.905 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.13 129.39 55.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 73.44 110.877 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.596 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.931 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.757 0.232 . . . . 75.43 112.317 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 pt -113.57 123.32 69.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 74.42 111.113 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.11 140.28 38.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 75.04 111.15 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -114.2 150.8 33.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 75.31 110.923 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.5 t -148.41 124.5 10.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 72.14 110.889 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -115.95 86.95 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 74.05 110.87 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -60.47 -15.81 30.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 75.1 110.821 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -70.41 -44.09 68.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 74.13 110.854 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 t -110.77 8.23 22.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 75.35 111.151 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.21 70.72 0.88 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.698 -0.763 . . . . 72.11 112.519 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 8.4 pttp -160.12 120.14 2.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.82 0.343 . . . . 70.22 110.932 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.75 165.16 27.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 73.04 110.824 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.482 ' O ' HD13 ' A' ' 9' ' ' ILE . 4.2 tt0 178.76 157.95 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 74.33 110.892 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.02 129.43 56.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 74.41 110.89 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.595 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.453 . . . . 64.22 110.899 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.143 0 CA-C-O 120.757 0.232 . . . . 74.12 112.346 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.7 pt -113.6 123.39 69.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 70.43 111.115 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -138.89 139.62 40.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 73.02 111.126 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -113.97 150.88 33.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 72.32 110.906 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.2 t -148.32 123.76 10.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 74.42 110.909 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -115.15 87.07 2.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 74.12 110.896 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -60.38 -15.76 29.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 72.21 110.871 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -70.49 -43.79 69.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 75.22 110.893 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 t -111.14 8.23 21.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 70.35 111.171 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.13 70.59 0.91 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.76 . . . . 74.52 112.481 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -159.74 119.74 2.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 74.14 110.882 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -138.98 164.16 30.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 72.45 110.909 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.471 ' O ' HD13 ' A' ' 9' ' ' ILE . 0.7 OUTLIER 178.69 157.32 0.48 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 75.14 110.903 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -115.6 129.57 56.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.52 110.858 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.6 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.14 110.898 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.149 0 CA-C-O 120.758 0.233 . . . . 74.22 112.375 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 pt -113.54 123.06 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 74.52 111.159 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.73 141.11 35.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 72.14 111.133 179.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -114.24 150.08 34.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 73.41 110.91 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.1 t -149.35 120.48 7.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 74.25 110.899 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -114.48 88.37 2.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 73.34 110.917 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -58.63 -17.81 25.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 73.22 110.835 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -56.18 4.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 74.35 110.895 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.5 t -92.15 8.86 36.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 74.12 111.128 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.17 68.44 1.42 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.768 -0.729 . . . . 63.23 112.455 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.6 mtpp -155.26 116.56 3.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.338 . . . . 75.52 110.855 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.9 m -136.11 157.01 47.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 70.21 110.861 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.481 ' O ' HD13 ' A' ' 9' ' ' ILE . 2.1 tt0 178.29 158.54 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 75.04 110.948 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.6 129.53 55.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 75.44 110.869 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 65.32 110.869 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.211 0 CA-C-O 120.754 0.231 . . . . 72.3 112.328 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 pt -113.45 123.83 69.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 74.33 111.139 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.512 ' HB ' ' CG ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -137.11 135.85 47.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 74.15 111.116 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.496 ' HD2' ' CE1' ' A' ' 21' ' ' PHE . 2.8 p90 -115.14 150.83 35.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 73.41 110.95 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.0 t -145.12 133.9 22.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 60.03 110.888 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -107.99 88.15 2.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 65.31 110.875 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.5 mtt180 -57.73 -16.46 11.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 75.53 110.878 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.9 mmt-85 -70.46 -31.01 67.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 73.32 110.874 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 t -129.35 8.47 5.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 63.21 111.137 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.47 74.81 0.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.719 -0.753 . . . . 52.23 112.516 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.416 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 3.3 pttt -162.22 120.9 2.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 74.04 110.905 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.95 170.99 12.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 62.52 110.902 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -176.66 154.84 1.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 72.13 110.952 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.512 ' CG ' ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -105.34 140.79 37.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 71.25 110.908 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.496 ' CE1' ' HD2' ' A' ' 10' ' ' TYR . 3.4 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 71.35 110.883 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.231 0.138 0 CA-C-O 120.751 0.23 . . . . 74.14 112.317 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.7 pt -113.62 123.13 68.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 74.21 111.131 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.37 140.7 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.11 111.134 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -114.36 150.41 34.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 74.52 110.898 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.7 t -149.25 123.66 9.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 74.14 110.879 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -113.57 88.82 2.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 75.53 110.884 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.8 mmm-85 -58.55 -17.72 23.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 75.41 110.896 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.27 -56.92 4.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 73.34 110.857 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.3 t -90.14 7.85 35.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 73.41 111.18 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.94 73.55 0.35 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.736 -0.745 . . . . 73.23 112.474 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.418 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -166.26 123.54 1.38 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.845 0.355 . . . . 74.55 110.882 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 m -139.19 165.26 27.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 65.43 110.885 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.485 ' O ' HD13 ' A' ' 9' ' ' ILE . 1.7 tt0 178.28 158.2 0.47 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 75.21 110.894 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -117.8 129.74 55.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 73.32 110.856 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.595 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 72.25 110.872 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.771 0.238 . . . . 75.22 112.332 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 pt -113.59 123.16 68.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 75.12 111.121 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.42 140.71 36.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 72.04 111.121 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -114.48 150.39 34.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 71.42 110.921 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.4 t -149.2 123.94 9.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 73.24 110.877 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -113.57 88.85 2.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 72.52 110.875 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -58.53 -17.74 23.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 65.34 110.845 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.9 mtt180 -76.22 -56.79 4.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 74.44 110.872 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.3 t -90.33 7.93 36.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 73.33 111.126 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.8 73.31 0.37 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.759 -0.734 . . . . 65.42 112.524 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 43.6 pttt -166.18 123.46 1.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 72.22 110.883 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.6 m -139.09 165.74 26.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 64.31 110.927 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.49 ' O ' HD12 ' A' ' 9' ' ' ILE . 0.4 OUTLIER 178.27 158.17 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 72.25 110.883 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -117.7 129.65 55.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 75.41 110.842 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.606 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 74.4 110.926 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.823 0.26 . . . . 74.24 112.342 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 pt -113.65 123.24 69.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 75.51 111.164 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -139.63 142.17 33.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 75.0 111.125 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -113.68 149.58 34.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.485 . . . . 74.32 110.897 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.91 116.99 6.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 70.53 110.896 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -116.83 86.32 2.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 73.4 110.878 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -60.61 -16.13 35.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 73.24 110.865 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -53.72 13.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 74.33 110.865 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.6 t -100.22 10.0 41.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.449 . . . . 72.3 111.129 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.56 72.46 0.55 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.749 -0.738 . . . . 44.34 112.517 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -154.38 114.35 3.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.814 0.34 . . . . 73.4 110.935 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.9 t -134.1 153.66 51.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 75.43 110.887 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.465 ' O ' HD12 ' A' ' 9' ' ' ILE . 0.4 OUTLIER 176.09 157.22 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 71.51 110.917 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -118.25 128.94 55.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 75.22 110.907 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.597 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 64.31 110.847 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.171 0 CA-C-O 120.783 0.243 . . . . 72.03 112.322 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 pt -113.4 124.0 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 71.24 111.148 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.517 ' HB ' ' CG ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -137.39 136.92 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 74.54 111.101 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.498 ' HD2' ' CE1' ' A' ' 21' ' ' PHE . 2.7 p90 -115.24 150.67 35.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 71.31 110.924 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.6 t -146.37 130.27 17.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 70.52 110.87 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -106.76 87.27 2.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 62.34 110.866 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.67 -16.43 10.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 75.35 110.867 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -69.85 -30.71 68.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 75.3 110.861 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 t -130.85 8.73 4.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 72.44 111.126 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.36 70.51 0.93 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.779 -0.724 . . . . 65.14 112.462 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.5 mttm -155.21 116.61 4.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.797 0.332 . . . . 72.14 110.839 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.02 171.08 12.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 61.01 110.895 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -179.54 156.55 0.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 73.01 110.905 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.517 ' CG ' ' HB ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -106.63 140.5 39.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 75.14 110.898 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.498 ' CE1' ' HD2' ' A' ' 10' ' ' TYR . 3.1 m-85 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.45 110.913 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.747 0.228 . . . . 54.33 112.324 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.55 123.33 69.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 74.41 111.155 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.04 140.01 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.457 . . . . 71.22 111.091 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -114.0 150.77 33.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 74.14 110.877 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.7 t -148.27 123.61 10.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 73.42 110.914 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -115.9 85.71 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.11 110.913 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -61.14 -15.08 29.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 74.33 110.89 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.69 -32.29 67.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 72.23 110.855 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.9 t -123.86 7.54 8.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.463 . . . . 74.21 111.131 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.79 67.19 2.35 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.762 -0.732 . . . . 72.14 112.511 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -154.64 115.33 3.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.347 . . . . 74.53 110.885 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 m -136.83 162.69 32.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 60.35 110.848 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.479 ' O ' HD11 ' A' ' 9' ' ' ILE . 3.6 tt0 178.87 157.8 0.52 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 64.43 110.946 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -116.61 129.24 56.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 75.23 110.881 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.613 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 73.32 110.901 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.145 0 CA-C-O 120.737 0.224 . . . . 65.41 112.354 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 pt -113.61 123.36 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 71.24 111.109 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.06 140.0 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 74.14 111.168 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -113.95 150.79 33.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 71.44 110.959 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.8 t -148.31 123.94 10.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 72.51 110.872 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -116.2 85.84 2.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 71.24 110.862 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -61.16 -15.06 29.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 72.13 110.914 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.2 mmm-85 -71.81 -32.25 67.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 74.44 110.869 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.9 t -123.85 7.48 8.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 74.43 111.079 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.77 67.09 2.4 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 73.45 112.506 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -154.61 115.36 3.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.819 0.342 . . . . 74.45 110.9 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.96 162.81 32.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 73.31 110.88 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.484 ' O ' HD12 ' A' ' 9' ' ' ILE . 0.3 OUTLIER 178.88 157.83 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 65.23 110.905 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -116.59 129.23 56.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 72.4 110.917 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.61 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 73.31 110.895 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.231 0.145 0 CA-C-O 120.73 0.221 . . . . 75.4 112.374 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.55 123.33 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 70.45 111.117 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.08 139.89 39.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 73.03 111.146 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -113.95 150.77 33.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 75.43 110.867 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.9 t -148.2 123.59 10.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 74.44 110.873 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -115.67 85.74 2.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 64.44 110.871 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -15.09 29.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 70.53 110.845 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -71.76 -32.21 67.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 63.4 110.872 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.9 t -123.93 7.56 8.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 72.35 111.096 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.74 67.2 2.34 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 61.45 112.489 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -154.77 115.37 3.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.369 . . . . 72.31 110.887 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.85 163.0 31.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 71.23 110.9 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.482 ' O ' HD12 ' A' ' 9' ' ' ILE . 0.3 OUTLIER 178.85 157.79 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 71.1 110.924 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.3 OUTLIER -116.55 129.22 56.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 72.22 110.871 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.61 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 75.42 110.856 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.232 0.207 0 CA-C-O 120.775 0.24 . . . . 71.24 112.4 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 pt -113.55 123.4 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 74.11 111.161 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -138.99 139.52 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 74.44 111.099 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -113.83 150.85 32.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.486 . . . . 75.43 110.91 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.4 t -148.22 123.33 10.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 71.05 110.878 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -115.54 85.77 2.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 60.52 110.91 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -15.18 29.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 75.13 110.894 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -71.67 -32.2 67.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 73.02 110.874 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.9 t -123.94 7.45 8.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 63.45 111.087 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.84 67.18 2.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.736 . . . . 73.44 112.446 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -154.68 115.2 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.877 0.37 . . . . 74.21 110.921 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -137.24 162.09 34.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 75.25 110.856 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.468 ' O ' HD11 ' A' ' 9' ' ' ILE . 3.5 tt0 179.02 157.3 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 72.34 110.891 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -115.48 129.45 56.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 74.3 110.874 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.617 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.881 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.482 -0.247 . . . . 73.33 112.482 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -99.46 -58.19 1.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.982 0.42 . . . . 75.53 110.843 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -94.27 156.89 16.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 75.31 110.912 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.4 mtmm -116.15 79.33 8.48 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.581 0.705 . . . . 75.54 110.851 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -35.02 13.58 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.723 2.282 . . . . 72.42 112.336 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.7 t -134.69 110.55 11.23 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.641 0.734 . . . . 73.42 111.119 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -173.6 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.727 2.284 . . . . 74.35 112.365 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 pt -113.49 123.91 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 74.15 111.109 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.516 ' HB ' ' CG ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -137.13 136.51 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 71.32 111.138 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.489 ' HD1' ' CE1' ' A' ' 21' ' ' PHE . 2.7 p90 -114.98 150.67 35.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.207 -0.451 . . . . 74.43 110.943 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.8 t -146.28 130.14 17.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 73.1 110.881 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -106.47 87.31 2.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 75.52 110.909 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -57.6 -16.52 10.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.857 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -69.74 -30.7 68.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 73.41 110.88 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 t -130.92 8.72 4.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 74.32 111.117 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.32 70.49 0.93 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.744 -0.741 . . . . 60.24 112.5 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -155.21 116.63 4.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 74.13 110.915 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.97 170.91 12.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 71.45 110.851 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.55 156.52 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 73.42 110.9 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.516 ' CG ' ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -106.45 140.68 38.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 74.54 110.868 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.489 ' CE1' ' HD1' ' A' ' 10' ' ' TYR . 3.1 m-85 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 74.32 110.88 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.492 -0.243 . . . . 73.42 112.492 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m -121.39 -54.54 1.98 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.916 0.388 . . . . 75.1 110.854 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -124.66 142.07 51.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 75.14 110.884 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.15 79.32 2.76 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.644 0.735 . . . . 73.02 110.893 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -32.82 18.06 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.738 2.292 . . . . 63.34 112.342 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.71 110.54 11.2 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.676 0.75 . . . . 74.02 111.144 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 179.71 3.5 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.673 2.249 . . . . 72.35 112.376 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.7 pt -113.58 123.34 69.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 74.12 111.089 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.13 140.01 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 75.32 111.142 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -113.96 150.82 33.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.892 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.7 t -148.31 123.56 10.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 70.01 110.907 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -115.82 85.79 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 75.4 110.867 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 -61.18 -15.05 29.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 73.54 110.862 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -71.79 -32.23 67.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 65.02 110.887 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.9 t -123.81 7.51 8.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 73.35 111.137 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.74 67.18 2.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 53.04 112.498 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -154.69 115.31 3.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.338 . . . . 75.23 110.9 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.89 162.75 32.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 54.14 110.873 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.481 ' O ' HD13 ' A' ' 9' ' ' ILE . 0.3 OUTLIER 178.98 157.87 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 73.22 110.949 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -116.57 129.22 56.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 73.31 110.902 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.605 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 75.44 110.898 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.254 0 N-CA-C 112.499 -0.241 . . . . 72.34 112.499 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.2 p -138.85 -69.46 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 63.34 110.843 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -100.03 171.85 7.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 65.04 110.877 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.14 79.41 3.63 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.552 0.692 . . . . 62.33 110.857 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.86 -32.82 17.43 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.683 2.256 . . . . 74.22 112.332 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.8 110.53 11.11 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.646 0.736 . . . . 75.54 111.103 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -176.55 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.654 2.236 . . . . 73.31 112.317 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 pt -113.64 123.13 68.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 74.23 111.115 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.67 141.08 35.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 71.22 111.119 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -114.25 150.09 34.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 63.45 110.925 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 t -149.25 120.65 7.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 62.44 110.878 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -114.41 88.31 2.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.477 . . . . 74.52 110.851 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -58.58 -17.82 24.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 74.33 110.846 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -76.26 -56.07 4.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 74.35 110.86 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.5 t -92.18 8.93 35.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 73.31 111.161 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.06 68.34 1.45 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.76 -0.733 . . . . 52.52 112.524 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -155.18 116.57 4.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.796 0.331 . . . . 74.02 110.938 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.5 m -136.03 157.06 47.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 62.32 110.846 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.474 ' O ' HD12 ' A' ' 9' ' ' ILE . 1.7 tt0 178.36 158.57 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 75.3 110.932 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -117.61 129.52 55.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.12 110.842 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.597 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 75.24 110.933 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.491 -0.244 . . . . 72.43 112.491 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -118.74 -63.59 1.39 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.915 0.388 . . . . 74.43 110.874 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.03 159.31 34.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 74.25 110.872 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.64 79.36 4.27 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.527 0.68 . . . . 75.35 110.888 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -32.83 17.57 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.633 2.222 . . . . 74.3 112.33 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.8 t -134.78 110.57 11.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.691 0.758 . . . . 73.24 111.128 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -173.03 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.648 2.232 . . . . 74.55 112.345 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 pt -113.64 123.12 68.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 64.42 111.088 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.65 141.05 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.472 . . . . 73.34 111.135 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -114.23 150.12 34.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 74.45 110.914 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.3 t -149.32 120.49 7.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 75.2 110.893 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -114.26 88.26 2.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 75.33 110.878 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -58.59 -17.8 24.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 73.43 110.859 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -76.15 -55.89 5.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 73.43 110.84 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.5 t -92.53 8.98 36.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 64.43 111.135 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.12 68.36 1.45 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 62.1 112.468 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -155.29 116.59 3.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 75.34 110.918 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.3 m -136.02 157.13 47.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 74.51 110.867 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.479 ' O ' HD12 ' A' ' 9' ' ' ILE . 4.0 tt0 178.38 158.49 0.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 75.5 110.951 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.59 129.51 55.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 75.14 110.894 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.606 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 61.04 110.908 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.498 -0.241 . . . . 71.13 112.498 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.28 -72.04 0.65 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 74.15 110.87 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -91.96 169.65 10.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 71.54 110.92 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -121.8 79.34 40.39 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.561 0.696 . . . . 74.14 110.874 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -33.52 16.41 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.647 2.231 . . . . 74.21 112.338 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.8 t -134.68 110.58 11.25 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.662 0.744 . . . . 73.04 111.105 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 174.32 9.63 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.688 2.259 . . . . 74.23 112.396 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 pt -113.63 123.23 69.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.44 . . . . 64.24 111.134 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -139.56 142.03 33.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 74.45 111.14 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -113.84 149.8 34.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 72.51 110.887 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.82 116.95 6.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 72.42 110.898 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -117.65 86.78 2.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.867 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.0 ptt85 -60.57 -16.05 33.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 74.42 110.9 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -71.97 -56.33 5.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 75.23 110.855 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.8 t -96.88 10.25 39.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 72.13 111.133 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.79 72.34 0.56 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.736 -0.745 . . . . 70.2 112.502 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -154.37 114.54 3.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.819 0.342 . . . . 75.41 110.868 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.4 t -135.33 152.65 51.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 73.12 110.899 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.479 ' O ' HD12 ' A' ' 9' ' ' ILE . 3.2 tt0 175.84 159.51 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 74.24 110.89 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -119.21 129.41 54.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 74.24 110.901 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.599 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 75.44 110.901 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.472 -0.251 . . . . 73.51 112.472 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.15 -66.58 0.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.934 0.397 . . . . 74.14 110.885 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.95 171.3 7.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 73.33 110.911 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -114.02 79.35 4.76 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.585 0.707 . . . . 71.24 110.916 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -32.73 18.19 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.723 2.282 . . . . 75.24 112.358 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.81 110.61 11.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.643 0.735 . . . . 74.53 111.12 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -174.86 1.0 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.726 2.284 . . . . 74.12 112.308 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.7 pt -113.49 123.33 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 75.33 111.153 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.1 140.2 38.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 73.2 111.11 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -114.18 150.81 33.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 74.43 110.952 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.7 t -148.41 125.02 11.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 63.35 110.861 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -116.23 87.12 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 73.41 110.919 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -15.79 29.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 74.11 110.895 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -44.63 66.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 75.12 110.871 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 t -110.27 8.53 23.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 74.1 111.163 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.79 70.24 1.02 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.737 . . . . 61.25 112.497 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 9.7 ptmt -159.34 119.91 3.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 74.41 110.879 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.58 165.19 27.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 74.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.482 ' O ' HD13 ' A' ' 9' ' ' ILE . 1.3 tt0 178.65 157.94 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 74.34 110.93 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.522 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.06 129.42 55.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 75.35 110.837 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.599 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 74.51 110.857 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.494 -0.242 . . . . 74.31 112.494 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -131.97 -70.46 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 73.43 110.898 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -138.43 160.03 40.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 74.51 110.892 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -127.82 79.38 73.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.619 0.723 . . . . 65.2 110.902 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -33.68 16.19 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.69 2.26 . . . . 72.22 112.345 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.7 t -134.7 110.57 11.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.601 0.715 . . . . 74.43 111.133 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 173.85 10.37 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.671 2.247 . . . . 75.34 112.35 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.7 pt -113.62 123.33 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 74.14 111.126 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.07 140.19 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 74.34 111.103 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -114.21 150.81 33.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 71.23 110.882 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.6 t -148.33 125.0 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 65.03 110.913 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -116.3 87.14 2.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 73.31 110.859 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -60.49 -15.71 29.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 74.21 110.881 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -70.6 -44.22 67.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 75.54 110.862 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 t -110.76 8.42 22.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 75.22 111.143 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.94 70.12 1.06 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.772 -0.727 . . . . 74.4 112.487 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 12.1 ptmt -159.25 119.87 3.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 74.2 110.909 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.59 165.23 27.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 73.21 110.86 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.48 ' O ' HD13 ' A' ' 9' ' ' ILE . 4.2 tt0 178.63 157.96 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 70.44 110.923 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.06 129.45 56.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 74.34 110.891 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.607 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.859 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.492 -0.243 . . . . 75.44 112.492 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.57 -50.66 0.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.903 0.382 . . . . 72.42 110.839 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.5 pttt -127.89 156.84 41.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 72.43 110.935 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.93 79.34 2.6 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.529 0.68 . . . . 75.13 110.882 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -32.58 18.05 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.673 2.249 . . . . 72.13 112.338 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.77 110.55 11.15 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.63 0.728 . . . . 73.41 111.13 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -171.64 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.7 2.267 . . . . 70.33 112.323 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 pt -113.57 123.28 69.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 74.34 111.151 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.13 140.27 38.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 72.32 111.147 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -114.2 150.76 33.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 72.45 110.909 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.7 t -148.4 124.98 11.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 73.31 110.894 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -116.35 87.06 2.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 72.41 110.882 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.34 -15.85 29.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 75.53 110.856 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.5 -45.21 66.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 75.35 110.836 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 t -109.63 8.39 24.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 74.23 111.098 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.9 71.02 0.79 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.798 -0.715 . . . . 42.45 112.476 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 42.0 pttt -160.29 120.21 2.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 72.43 110.878 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.76 165.1 27.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 74.15 110.868 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.486 ' O ' HD12 ' A' ' 9' ' ' ILE . 0.3 OUTLIER 178.76 158.04 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 75.2 110.905 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.13 129.39 55.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 73.44 110.877 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.596 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.931 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.472 -0.251 . . . . 72.41 112.472 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.71 -56.25 1.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.982 0.42 . . . . 72.3 110.853 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -134.28 153.64 51.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 74.14 110.903 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -113.47 79.34 4.03 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.553 0.692 . . . . 73.53 110.89 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -32.48 18.43 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.693 2.262 . . . . 74.22 112.303 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.67 110.58 11.25 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.608 0.718 . . . . 62.53 111.109 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -172.17 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.681 2.254 . . . . 75.43 112.317 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 pt -113.57 123.32 69.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 74.42 111.113 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.11 140.28 38.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 75.04 111.15 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -114.2 150.8 33.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 75.31 110.923 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.5 t -148.41 124.5 10.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 72.14 110.889 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -115.95 86.95 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 74.05 110.87 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -60.47 -15.81 30.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 75.1 110.821 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -70.41 -44.09 68.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 74.13 110.854 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 t -110.77 8.23 22.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 75.35 111.151 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.21 70.72 0.88 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.698 -0.763 . . . . 72.11 112.519 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 8.4 pttp -160.12 120.14 2.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.82 0.343 . . . . 70.22 110.932 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.75 165.16 27.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 73.04 110.824 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.482 ' O ' HD13 ' A' ' 9' ' ' ILE . 4.2 tt0 178.76 157.95 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 74.33 110.892 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.02 129.43 56.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 74.41 110.89 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.595 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.453 . . . . 64.22 110.899 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.52 -0.232 . . . . 64.32 112.52 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.27 -64.67 1.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.945 0.403 . . . . 75.34 110.851 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.0 mttt -116.82 160.17 21.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.924 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.67 79.38 16.25 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.562 0.696 . . . . 63.43 110.895 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -32.49 18.4 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.73 2.287 . . . . 73.34 112.331 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.74 110.56 11.17 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.645 0.736 . . . . 75.41 111.126 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -171.16 0.45 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.656 2.238 . . . . 74.12 112.346 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.7 pt -113.6 123.39 69.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 70.43 111.115 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -138.89 139.62 40.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 73.02 111.126 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -113.97 150.88 33.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 72.32 110.906 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.2 t -148.32 123.76 10.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 74.42 110.909 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -115.15 87.07 2.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 74.12 110.896 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -60.38 -15.76 29.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 72.21 110.871 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -70.49 -43.79 69.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 75.22 110.893 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 t -111.14 8.23 21.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 70.35 111.171 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.13 70.59 0.91 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.76 . . . . 74.52 112.481 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -159.74 119.74 2.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 74.14 110.882 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -138.98 164.16 30.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 72.45 110.909 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.471 ' O ' HD13 ' A' ' 9' ' ' ILE . 0.7 OUTLIER 178.69 157.32 0.48 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 75.14 110.903 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -115.6 129.57 56.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.52 110.858 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.6 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.14 110.898 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.54 -0.224 . . . . 65.13 112.54 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -130.6 -68.49 0.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.895 0.379 . . . . 54.11 110.883 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -130.8 171.1 13.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 73.3 110.91 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -111.99 79.33 2.64 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.58 0.705 . . . . 72.23 110.905 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -33.52 16.38 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.683 2.255 . . . . 72.22 112.356 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.7 t -134.76 110.55 11.15 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.72 . . . . 73.12 111.103 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -174.63 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.704 2.269 . . . . 74.22 112.375 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 pt -113.54 123.06 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 74.52 111.159 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.73 141.11 35.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 72.14 111.133 179.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -114.24 150.08 34.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 73.41 110.91 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.1 t -149.35 120.48 7.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 74.25 110.899 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -114.48 88.37 2.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 73.34 110.917 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -58.63 -17.81 25.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 73.22 110.835 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -56.18 4.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 74.35 110.895 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.5 t -92.15 8.86 36.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 74.12 111.128 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.17 68.44 1.42 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.768 -0.729 . . . . 63.23 112.455 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.6 mtpp -155.26 116.56 3.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.338 . . . . 75.52 110.855 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.9 m -136.11 157.01 47.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 70.21 110.861 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.481 ' O ' HD13 ' A' ' 9' ' ' ILE . 2.1 tt0 178.29 158.54 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 75.04 110.948 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.6 129.53 55.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 75.44 110.869 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.602 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 65.32 110.869 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.446 -0.262 . . . . 72.53 112.446 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.0 t -105.19 -65.92 1.01 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.899 0.38 . . . . 74.03 110.817 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.49 162.41 13.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 65.43 110.892 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.0 mttp -127.63 79.35 73.61 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.608 0.718 . . . . 75.4 110.917 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -38.49 7.72 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.719 2.279 . . . . 75.34 112.314 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.7 t -134.73 110.61 11.19 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.595 0.712 . . . . 73.11 111.104 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -170.96 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.703 2.268 . . . . 72.3 112.328 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 pt -113.45 123.83 69.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 74.33 111.139 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.512 ' HB ' ' CG ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -137.11 135.85 47.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 74.15 111.116 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.496 ' HD2' ' CE1' ' A' ' 21' ' ' PHE . 2.8 p90 -115.14 150.83 35.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 73.41 110.95 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.0 t -145.12 133.9 22.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 60.03 110.888 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -107.99 88.15 2.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 65.31 110.875 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.5 mtt180 -57.73 -16.46 11.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 75.53 110.878 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.9 mmt-85 -70.46 -31.01 67.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 73.32 110.874 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 t -129.35 8.47 5.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 63.21 111.137 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.47 74.81 0.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.719 -0.753 . . . . 52.23 112.516 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.416 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 3.3 pttt -162.22 120.9 2.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 74.04 110.905 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.95 170.99 12.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 62.52 110.902 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -176.66 154.84 1.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 72.13 110.952 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.512 ' CG ' ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -105.34 140.79 37.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 71.25 110.908 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.496 ' CE1' ' HD2' ' A' ' 10' ' ' TYR . 3.4 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 71.35 110.883 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.452 -0.259 . . . . 65.44 112.452 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -121.74 -65.0 1.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.946 0.403 . . . . 72.34 110.879 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -98.06 173.54 6.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 75.24 110.867 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -112.3 79.39 2.9 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.639 0.733 . . . . 74.41 110.916 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -32.58 18.39 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.696 2.264 . . . . 74.34 112.36 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.5 t -134.71 110.56 11.21 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.643 0.735 . . . . 63.24 111.14 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -174.94 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.689 2.26 . . . . 74.14 112.317 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.7 pt -113.62 123.13 68.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 74.21 111.131 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.37 140.7 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.11 111.134 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -114.36 150.41 34.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 74.52 110.898 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.7 t -149.25 123.66 9.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 74.14 110.879 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -113.57 88.82 2.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 75.53 110.884 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.8 mmm-85 -58.55 -17.72 23.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 75.41 110.896 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.27 -56.92 4.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 73.34 110.857 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.3 t -90.14 7.85 35.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 73.41 111.18 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.94 73.55 0.35 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.736 -0.745 . . . . 73.23 112.474 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.418 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -166.26 123.54 1.38 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.845 0.355 . . . . 74.55 110.882 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 m -139.19 165.26 27.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 65.43 110.885 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.485 ' O ' HD13 ' A' ' 9' ' ' ILE . 1.7 tt0 178.28 158.2 0.47 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 75.21 110.894 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -117.8 129.74 55.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 73.32 110.856 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.595 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 72.25 110.872 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.481 -0.248 . . . . 72.3 112.481 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.3 t -122.65 -69.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.927 0.394 . . . . 74.43 110.844 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -109.02 158.72 17.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.107 -0.497 . . . . 74.01 110.903 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -125.43 79.32 67.04 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.584 0.707 . . . . 74.14 110.898 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -33.11 17.23 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.721 2.281 . . . . 70.02 112.316 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.7 t -134.77 110.58 11.14 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.59 0.709 . . . . 73.33 111.14 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -178.2 2.24 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.63 2.22 . . . . 75.22 112.332 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 pt -113.59 123.16 68.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 75.12 111.121 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.42 140.71 36.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 72.04 111.121 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -114.48 150.39 34.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 71.42 110.921 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.4 t -149.2 123.94 9.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 73.24 110.877 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -113.57 88.85 2.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 72.52 110.875 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -58.53 -17.74 23.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 65.34 110.845 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.9 mtt180 -76.22 -56.79 4.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 74.44 110.872 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.3 t -90.33 7.93 36.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 73.33 111.126 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.8 73.31 0.37 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.759 -0.734 . . . . 65.42 112.524 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 43.6 pttt -166.18 123.46 1.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 72.22 110.883 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.6 m -139.09 165.74 26.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 64.31 110.927 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.49 ' O ' HD12 ' A' ' 9' ' ' ILE . 0.4 OUTLIER 178.27 158.17 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 72.25 110.883 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -117.7 129.65 55.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 75.41 110.842 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.606 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 74.4 110.926 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.495 -0.242 . . . . 75.21 112.495 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.38 -71.91 0.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.97 0.414 . . . . 55.21 110.857 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.61 159.98 15.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 65.42 110.893 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.39 79.31 2.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.603 0.716 . . . . 75.2 110.873 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -34.46 14.62 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.709 2.272 . . . . 75.14 112.316 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.65 110.55 11.26 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.637 0.732 . . . . 71.21 111.117 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 179.39 3.69 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.699 2.266 . . . . 74.24 112.342 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 pt -113.65 123.24 69.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 75.51 111.164 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -139.63 142.17 33.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 75.0 111.125 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -113.68 149.58 34.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.485 . . . . 74.32 110.897 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.91 116.99 6.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 70.53 110.896 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -116.83 86.32 2.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 73.4 110.878 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -60.61 -16.13 35.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 73.24 110.865 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -53.72 13.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 74.33 110.865 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.6 t -100.22 10.0 41.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.449 . . . . 72.3 111.129 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.56 72.46 0.55 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.749 -0.738 . . . . 44.34 112.517 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -154.38 114.35 3.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.814 0.34 . . . . 73.4 110.935 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.9 t -134.1 153.66 51.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 75.43 110.887 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.465 ' O ' HD12 ' A' ' 9' ' ' ILE . 0.4 OUTLIER 176.09 157.22 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 71.51 110.917 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -118.25 128.94 55.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 75.22 110.907 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.597 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 64.31 110.847 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.478 -0.249 . . . . 72.23 112.478 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.53 -59.41 1.8 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.969 0.414 . . . . 74.42 110.891 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.9 pttt -108.32 147.77 31.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.509 . . . . 73.41 110.875 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -131.26 79.34 70.55 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.532 0.682 . . . . 75.2 110.853 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -47.24 0.96 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.683 2.255 . . . . 71.42 112.361 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 p -100.56 110.25 59.79 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.61 0.719 . . . . 72.3 111.101 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 -178.76 2.53 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.657 2.238 . . . . 72.03 112.322 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 pt -113.4 124.0 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 71.24 111.148 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.517 ' HB ' ' CG ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -137.39 136.92 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 74.54 111.101 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.498 ' HD2' ' CE1' ' A' ' 21' ' ' PHE . 2.7 p90 -115.24 150.67 35.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 71.31 110.924 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.6 t -146.37 130.27 17.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 70.52 110.87 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -106.76 87.27 2.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 62.34 110.866 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.67 -16.43 10.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 75.35 110.867 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -69.85 -30.71 68.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 75.3 110.861 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 t -130.85 8.73 4.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 72.44 111.126 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.36 70.51 0.93 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.779 -0.724 . . . . 65.14 112.462 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.5 mttm -155.21 116.61 4.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.797 0.332 . . . . 72.14 110.839 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.02 171.08 12.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 61.01 110.895 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -179.54 156.55 0.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 73.01 110.905 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.517 ' CG ' ' HB ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -106.63 140.5 39.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 75.14 110.898 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.498 ' CE1' ' HD2' ' A' ' 10' ' ' TYR . 3.1 m-85 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.45 110.913 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.503 -0.239 . . . . 75.11 112.503 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.63 -67.3 0.76 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.964 0.412 . . . . 71.52 110.867 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.88 156.26 17.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.506 . . . . 72.44 110.868 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -121.8 79.37 40.35 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.537 0.684 . . . . 74.3 110.885 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -43.93 2.39 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.714 2.276 . . . . 72.14 112.328 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 p -100.5 110.21 59.57 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.629 0.728 . . . . 75.23 111.172 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 178.39 4.63 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.715 2.277 . . . . 54.33 112.324 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.55 123.33 69.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 74.41 111.155 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.04 140.01 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.457 . . . . 71.22 111.091 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -114.0 150.77 33.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 74.14 110.877 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.7 t -148.27 123.61 10.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 73.42 110.914 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -115.9 85.71 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.11 110.913 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -61.14 -15.08 29.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 74.33 110.89 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.69 -32.29 67.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 72.23 110.855 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.9 t -123.86 7.54 8.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.463 . . . . 74.21 111.131 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.79 67.19 2.35 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.762 -0.732 . . . . 72.14 112.511 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -154.64 115.33 3.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.347 . . . . 74.53 110.885 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 m -136.83 162.69 32.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 60.35 110.848 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.479 ' O ' HD11 ' A' ' 9' ' ' ILE . 3.6 tt0 178.87 157.8 0.52 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 64.43 110.946 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -116.61 129.24 56.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 75.23 110.881 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.613 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 73.32 110.901 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.464 -0.255 . . . . 72.44 112.464 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.24 -59.3 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.971 0.415 . . . . 75.34 110.909 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -132.88 130.64 39.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 73.42 110.866 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.2 79.35 6.46 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.57 0.7 . . . . 65.12 110.855 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -43.64 2.55 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.626 2.217 . . . . 73.32 112.36 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 p -100.52 110.22 59.62 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.644 0.735 . . . . 74.14 111.154 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -178.34 2.31 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.698 2.266 . . . . 65.41 112.354 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 pt -113.61 123.36 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 71.24 111.109 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.06 140.0 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 74.14 111.168 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -113.95 150.79 33.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 71.44 110.959 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.8 t -148.31 123.94 10.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 72.51 110.872 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -116.2 85.84 2.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 71.24 110.862 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -61.16 -15.06 29.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 72.13 110.914 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.2 mmm-85 -71.81 -32.25 67.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 74.44 110.869 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.9 t -123.85 7.48 8.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 74.43 111.079 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.77 67.09 2.4 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 73.45 112.506 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -154.61 115.36 3.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.819 0.342 . . . . 74.45 110.9 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.96 162.81 32.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 73.31 110.88 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.484 ' O ' HD12 ' A' ' 9' ' ' ILE . 0.3 OUTLIER 178.88 157.83 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 65.23 110.905 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -116.59 129.23 56.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 72.4 110.917 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.61 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 73.31 110.895 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.479 -0.248 . . . . 71.13 112.479 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 t -127.94 -53.61 1.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.977 0.418 . . . . 74.42 110.847 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.97 144.45 35.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 72.52 110.878 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -116.35 79.42 8.99 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.583 0.706 . . . . 73.12 110.894 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -47.45 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.678 2.252 . . . . 75.54 112.342 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 p -100.57 110.19 59.61 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.581 0.705 . . . . 74.54 111.157 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -177.25 1.79 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.655 2.236 . . . . 75.4 112.374 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.55 123.33 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 70.45 111.117 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -139.08 139.89 39.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 73.03 111.146 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -113.95 150.77 33.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 75.43 110.867 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.9 t -148.2 123.59 10.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 74.44 110.873 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -115.67 85.74 2.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 64.44 110.871 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -15.09 29.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 70.53 110.845 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -71.76 -32.21 67.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 63.4 110.872 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.9 t -123.93 7.56 8.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 72.35 111.096 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.74 67.2 2.34 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 61.45 112.489 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -154.77 115.37 3.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.369 . . . . 72.31 110.887 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.85 163.0 31.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 71.23 110.9 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.482 ' O ' HD12 ' A' ' 9' ' ' ILE . 0.3 OUTLIER 178.85 157.79 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 71.1 110.924 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.3 OUTLIER -116.55 129.22 56.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 72.22 110.871 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.61 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 75.42 110.856 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.488 -0.245 . . . . 74.24 112.488 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -135.22 -69.08 0.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.866 0.365 . . . . 72.51 110.875 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.95 161.55 28.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 75.35 110.933 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.1 mttt -117.71 79.28 12.75 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.575 0.703 . . . . 74.21 110.935 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -45.82 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.703 2.269 . . . . 71.54 112.363 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.3 p -100.58 110.21 59.72 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.65 0.738 . . . . 72.33 111.101 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 169.41 18.95 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.682 2.255 . . . . 71.24 112.4 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 pt -113.55 123.4 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 74.11 111.161 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -138.99 139.52 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 74.44 111.099 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -113.83 150.85 32.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.486 . . . . 75.43 110.91 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.4 t -148.22 123.33 10.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 71.05 110.878 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -115.54 85.77 2.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 60.52 110.91 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -15.18 29.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 75.13 110.894 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -71.67 -32.2 67.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 73.02 110.874 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.9 t -123.94 7.45 8.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 63.45 111.087 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.84 67.18 2.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.736 . . . . 73.44 112.446 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -154.68 115.2 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.877 0.37 . . . . 74.21 110.921 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -137.24 162.09 34.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 75.25 110.856 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.468 ' O ' HD11 ' A' ' 9' ' ' ILE . 3.5 tt0 179.02 157.3 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 72.34 110.891 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -115.48 129.45 56.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 74.3 110.874 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.617 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.881 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.149 0 CA-C-O 120.773 0.239 . . . . 62.43 112.365 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 pt -113.49 123.91 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 51.42 111.109 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.814 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -137.13 136.51 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 70.21 111.138 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.814 ' N ' HD12 ' A' ' 9' ' ' ILE . 2.7 p90 -114.98 150.67 35.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.207 -0.451 . . . . 45.31 110.943 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.8 t -146.28 130.14 17.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 73.1 110.881 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.433 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.6 m-20 -106.47 87.31 2.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 75.52 110.909 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -57.6 -16.52 10.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 73.34 110.857 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -69.74 -30.7 68.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 62.14 110.88 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.433 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.6 t -130.92 8.72 4.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 74.32 111.117 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.32 70.49 0.93 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.744 -0.741 . . . . 35.21 112.5 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -155.21 116.63 4.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 72.32 110.915 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.97 170.91 12.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 51.35 110.851 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.55 156.52 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 72.51 110.9 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.515 ' CG ' ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -106.45 140.68 38.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 74.54 110.868 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.486 ' CE1' ' HD1' ' A' ' 10' ' ' TYR . 3.1 m-85 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 70.42 110.88 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.231 0.156 0 CA-C-O 120.737 0.224 . . . . 72.35 112.376 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.7 pt -113.58 123.34 69.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 52.11 111.089 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.84 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.13 140.01 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 75.32 111.142 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.84 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -113.96 150.82 33.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.892 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.7 t -148.31 123.56 10.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 61.54 110.907 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.567 ' HB3' HG22 ' A' ' 15' ' ' THR . 2.1 m-80 -115.82 85.79 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 75.4 110.867 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 -61.18 -15.05 29.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 71.21 110.862 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -71.79 -32.23 67.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 53.03 110.887 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.567 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.9 t -123.81 7.51 8.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 73.35 111.137 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.74 67.18 2.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 53.04 112.498 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -154.69 115.31 3.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.338 . . . . 75.23 110.9 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.89 162.75 32.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 54.14 110.873 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 178.98 157.87 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 45.12 110.949 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -116.57 129.22 56.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 73.31 110.902 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.6 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 75.44 110.898 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.148 0 CA-C-O 120.797 0.249 . . . . 73.31 112.317 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.444 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.5 pt -113.64 123.13 68.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 55.41 111.115 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.825 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.67 141.08 35.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 64.21 111.119 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.825 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.6 p90 -114.25 150.09 34.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 50.11 110.925 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 t -149.25 120.65 7.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 62.44 110.878 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.484 ' HB3' HG22 ' A' ' 15' ' ' THR . 31.4 m120 -114.41 88.31 2.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.477 . . . . 73.15 110.851 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -58.58 -17.82 24.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 65.53 110.846 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -76.26 -56.07 4.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 74.35 110.86 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.5 t -92.18 8.93 35.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 73.31 111.161 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.06 68.34 1.45 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.76 -0.733 . . . . 44.25 112.524 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -155.18 116.57 4.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.796 0.331 . . . . 74.02 110.938 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.5 m -136.03 157.06 47.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 54.22 110.846 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.411 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 3.8 tt0 178.36 158.57 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 63.34 110.932 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -117.61 129.52 55.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.12 110.842 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.594 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 75.24 110.933 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.81 0.254 . . . . 74.12 112.345 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.5 pt -113.64 123.12 68.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 64.42 111.088 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.835 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.65 141.05 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.472 . . . . 72.14 111.135 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.835 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.6 p90 -114.23 150.12 34.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 74.45 110.914 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.3 t -149.32 120.49 7.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 75.2 110.893 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.482 ' HB3' HG22 ' A' ' 15' ' ' THR . 31.2 m120 -114.26 88.26 2.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.44 110.878 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -58.59 -17.8 24.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 72.01 110.859 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -76.15 -55.89 5.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 61.3 110.84 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.482 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.5 t -92.53 8.98 36.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 64.43 111.135 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.12 68.36 1.45 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 62.1 112.468 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -155.29 116.59 3.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 61.11 110.918 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.3 m -136.02 157.13 47.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 65.31 110.867 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.406 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 4.0 tt0 178.38 158.49 0.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 75.5 110.951 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.59 129.51 55.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 75.14 110.894 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.601 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 51.23 110.908 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.194 0 CA-C-O 120.752 0.23 . . . . 74.23 112.396 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.5 pt -113.63 123.23 69.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.44 . . . . 55.02 111.134 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.842 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -139.56 142.03 33.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 72.34 111.14 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.842 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.5 p90 -113.84 149.8 34.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 72.35 110.887 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.82 116.95 6.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 72.42 110.898 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.42 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.7 m-80 -117.65 86.78 2.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.867 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.0 ptt85 -60.57 -16.05 33.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 74.42 110.9 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -71.97 -56.33 5.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 74.51 110.855 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.42 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.8 t -96.88 10.25 39.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 72.13 111.133 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.79 72.34 0.56 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.736 -0.745 . . . . 70.2 112.502 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -154.37 114.54 3.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.819 0.342 . . . . 42.33 110.868 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.4 t -135.33 152.65 51.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 73.12 110.899 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.42 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 3.2 tt0 175.84 159.51 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 74.24 110.89 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -119.21 129.41 54.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 73.31 110.901 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.594 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 75.44 110.901 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.768 0.237 . . . . 74.12 112.308 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.4 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.7 pt -113.49 123.33 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 75.33 111.153 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.825 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.1 140.2 38.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 73.2 111.11 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.825 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -114.18 150.81 33.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 73.34 110.952 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.7 t -148.41 125.02 11.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 63.35 110.861 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.465 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.8 m-80 -116.23 87.12 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 73.41 110.919 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -15.79 29.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 62.32 110.895 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -44.63 66.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 75.12 110.871 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.465 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.2 t -110.27 8.53 23.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 70.43 111.163 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.79 70.24 1.02 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.737 . . . . 51.22 112.497 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 9.7 ptmt -159.34 119.91 3.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 74.41 110.879 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.58 165.19 27.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 62.23 110.887 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.4 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 3.8 tt0 178.65 157.94 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 73.12 110.93 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.06 129.42 55.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 75.35 110.837 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.595 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 73.45 110.857 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.769 0.237 . . . . 75.34 112.35 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.7 pt -113.62 123.33 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 74.14 111.126 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.841 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.07 140.19 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 74.34 111.103 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.841 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -114.21 150.81 33.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 71.23 110.882 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.6 t -148.33 125.0 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 52.12 110.913 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.478 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.8 m-80 -116.3 87.14 2.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 73.31 110.859 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -60.49 -15.71 29.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 73.14 110.881 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -70.6 -44.22 67.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 75.2 110.862 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.478 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.2 t -110.76 8.42 22.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 75.21 111.143 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.94 70.12 1.06 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.772 -0.727 . . . . 74.4 112.487 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 12.1 ptmt -159.25 119.87 3.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 74.2 110.909 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.59 165.23 27.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 73.21 110.86 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 178.63 157.96 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 53.34 110.923 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.06 129.45 56.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 74.33 110.891 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.604 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.859 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.156 0 CA-C-O 120.767 0.236 . . . . 34.13 112.323 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.414 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.6 pt -113.57 123.28 69.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 74.34 111.151 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.13 140.27 38.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 72.32 111.147 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.838 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -114.2 150.76 33.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 72.11 110.909 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.7 t -148.4 124.98 11.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 73.31 110.894 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.467 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.8 m-80 -116.35 87.06 2.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 63.54 110.882 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.34 -15.85 29.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 75.53 110.856 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.5 -45.21 66.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 71.4 110.836 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.1 t -109.63 8.39 24.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 61.44 111.098 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.9 71.02 0.79 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.798 -0.715 . . . . 35.32 112.476 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 42.0 pttt -160.29 120.21 2.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 52.41 110.878 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.76 165.1 27.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 43.45 110.868 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 178.76 158.04 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 63.45 110.905 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.13 129.39 55.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 73.44 110.877 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.594 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.931 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.757 0.232 . . . . 72.3 112.317 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.417 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.6 pt -113.57 123.32 69.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 54.13 111.113 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.824 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.11 140.28 38.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 75.04 111.15 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.824 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -114.2 150.8 33.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 65.14 110.923 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.5 t -148.41 124.5 10.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 72.14 110.889 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.464 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.8 m-80 -115.95 86.95 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 60.32 110.87 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -60.47 -15.81 30.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 75.1 110.821 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -70.41 -44.09 68.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 74.13 110.854 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.464 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.1 t -110.77 8.23 22.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 74.52 111.151 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.21 70.72 0.88 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.698 -0.763 . . . . 72.11 112.519 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 8.4 pttp -160.12 120.14 2.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.82 0.343 . . . . 70.22 110.932 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.75 165.16 27.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 73.04 110.824 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.401 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 4.2 tt0 178.76 157.95 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 74.33 110.892 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.02 129.43 56.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 74.41 110.89 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.591 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.453 . . . . 64.22 110.899 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.143 0 CA-C-O 120.757 0.232 . . . . 62.25 112.346 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.7 pt -113.6 123.39 69.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 70.43 111.115 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -138.89 139.62 40.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 71.21 111.126 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.838 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.3 p90 -113.97 150.88 33.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 63.43 110.906 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.2 t -148.32 123.76 10.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 74.42 110.909 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.475 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.7 m-80 -115.15 87.07 2.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 72.31 110.896 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -60.38 -15.76 29.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 72.21 110.871 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -70.49 -43.79 69.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 72.54 110.893 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.475 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.3 t -111.14 8.23 21.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 70.35 111.171 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.13 70.59 0.91 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.76 . . . . 74.52 112.481 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -159.74 119.74 2.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 73.34 110.882 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -138.98 164.16 30.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 72.45 110.909 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 178.69 157.32 0.48 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 74.2 110.903 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.549 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -115.6 129.57 56.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.52 110.858 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.595 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.14 110.898 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.149 0 CA-C-O 120.758 0.233 . . . . 74.22 112.375 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.446 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.5 pt -113.54 123.06 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 41.23 111.159 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.73 141.11 35.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 71.5 111.133 179.837 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.838 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.6 p90 -114.24 150.08 34.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 73.41 110.91 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.1 t -149.35 120.48 7.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 60.1 110.899 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.472 ' HB3' HG22 ' A' ' 15' ' ' THR . 30.6 m120 -114.48 88.37 2.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 73.34 110.917 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -58.63 -17.81 25.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 64.41 110.835 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -56.18 4.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 74.35 110.895 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.472 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.5 t -92.15 8.86 36.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 43.34 111.128 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.17 68.44 1.42 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.768 -0.729 . . . . 63.23 112.455 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.6 mtpp -155.26 116.56 3.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.338 . . . . 64.34 110.855 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.9 m -136.11 157.01 47.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 70.21 110.861 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.404 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 2.1 tt0 178.29 158.54 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 55.51 110.948 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.508 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.6 129.53 55.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 54.43 110.869 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.598 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 65.32 110.869 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.211 0 CA-C-O 120.754 0.231 . . . . 53.54 112.328 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 pt -113.45 123.83 69.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 74.33 111.139 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.818 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -137.11 135.85 47.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 55.25 111.116 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.818 ' N ' HD12 ' A' ' 9' ' ' ILE . 2.8 p90 -115.14 150.83 35.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 63.42 110.95 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.0 t -145.12 133.9 22.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 50.02 110.888 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.469 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.5 m-20 -107.99 88.15 2.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 63.43 110.875 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.5 mtt180 -57.73 -16.46 11.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 75.53 110.878 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.9 mmt-85 -70.46 -31.01 67.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 72.21 110.874 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.469 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.0 t -129.35 8.47 5.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 63.21 111.137 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.47 74.81 0.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.719 -0.753 . . . . 33.42 112.516 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.416 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 3.3 pttt -162.22 120.9 2.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 74.04 110.905 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.95 170.99 12.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 62.52 110.902 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -176.66 154.84 1.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 60.01 110.952 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.509 ' CG ' ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -105.34 140.79 37.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 71.25 110.908 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.493 ' CE1' ' HD2' ' A' ' 10' ' ' TYR . 3.4 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 65.02 110.883 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.231 0.138 0 CA-C-O 120.751 0.23 . . . . 74.14 112.317 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.406 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.7 pt -113.62 123.13 68.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 74.21 111.131 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.829 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.37 140.7 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.11 111.134 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.829 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.6 p90 -114.36 150.41 34.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 74.52 110.898 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.7 t -149.25 123.66 9.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 73.4 110.879 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.528 ' HB3' HG22 ' A' ' 15' ' ' THR . 33.7 m120 -113.57 88.82 2.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 71.32 110.884 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.8 mmm-85 -58.55 -17.72 23.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 74.31 110.896 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.27 -56.92 4.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 73.34 110.857 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.528 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.3 t -90.14 7.85 35.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 71.3 111.18 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.94 73.55 0.35 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.736 -0.745 . . . . 62.23 112.474 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.418 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -166.26 123.54 1.38 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.845 0.355 . . . . 74.55 110.882 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 m -139.19 165.26 27.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 44.1 110.885 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.402 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 3.7 tt0 178.28 158.2 0.47 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 74.1 110.894 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -117.8 129.74 55.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 73.32 110.856 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.591 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 72.25 110.872 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.771 0.238 . . . . 75.22 112.332 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.41 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.6 pt -113.59 123.16 68.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 74.0 111.121 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.847 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.42 140.71 36.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 65.15 111.121 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.847 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.6 p90 -114.48 150.39 34.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 71.42 110.921 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.4 t -149.2 123.94 9.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 73.24 110.877 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.529 ' HB3' HG22 ' A' ' 15' ' ' THR . 33.7 m120 -113.57 88.85 2.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 72.41 110.875 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -58.53 -17.74 23.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 54.44 110.845 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.9 mtt180 -76.22 -56.79 4.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 74.44 110.872 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.529 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.3 t -90.33 7.93 36.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 72.34 111.126 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.8 73.31 0.37 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.759 -0.734 . . . . 65.42 112.524 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 43.6 pttt -166.18 123.46 1.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 63.31 110.883 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.6 m -139.09 165.74 26.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 64.31 110.927 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 178.27 158.17 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 72.25 110.883 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -117.7 129.65 55.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 75.41 110.842 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.602 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 74.4 110.926 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.823 0.26 . . . . 74.24 112.342 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.3 pt -113.65 123.24 69.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 75.51 111.164 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.835 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -139.63 142.17 33.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 64.21 111.125 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.835 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -113.68 149.58 34.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.485 . . . . 71.53 110.897 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.91 116.99 6.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 70.53 110.896 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.415 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.5 m-80 -116.83 86.32 2.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 73.4 110.878 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -60.61 -16.13 35.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 72.23 110.865 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -53.72 13.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 74.33 110.865 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.415 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.6 t -100.22 10.0 41.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.449 . . . . 72.3 111.129 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.56 72.46 0.55 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.749 -0.738 . . . . 44.34 112.517 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -154.38 114.35 3.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.814 0.34 . . . . 73.4 110.935 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.9 t -134.1 153.66 51.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 75.43 110.887 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 176.09 157.22 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 71.51 110.917 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -118.25 128.94 55.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 74.23 110.907 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.594 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 64.31 110.847 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.171 0 CA-C-O 120.783 0.243 . . . . 70.21 112.322 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 pt -113.4 124.0 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 71.24 111.148 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.836 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -137.39 136.92 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 74.54 111.101 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.836 ' N ' HD12 ' A' ' 9' ' ' ILE . 2.7 p90 -115.24 150.67 35.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 71.31 110.924 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.6 t -146.37 130.27 17.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 70.52 110.87 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.443 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.6 m-20 -106.76 87.27 2.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 53.32 110.866 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.67 -16.43 10.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 71.33 110.867 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -69.85 -30.71 68.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 71.21 110.861 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.443 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.6 t -130.85 8.73 4.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 72.44 111.126 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.36 70.51 0.93 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.779 -0.724 . . . . 65.14 112.462 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.5 mttm -155.21 116.61 4.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.797 0.332 . . . . 53.22 110.839 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.02 171.08 12.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 54.45 110.895 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -179.54 156.55 0.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 73.01 110.905 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.516 ' CG ' ' HB ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -106.63 140.5 39.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 75.14 110.898 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.496 ' CE1' ' HD2' ' A' ' 10' ' ' TYR . 3.1 m-85 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.45 110.913 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.747 0.228 . . . . 45.03 112.324 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.402 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.8 pt -113.55 123.33 69.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 74.41 111.155 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.828 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.04 140.01 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.457 . . . . 65.44 111.091 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.828 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -114.0 150.77 33.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 74.14 110.877 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.7 t -148.27 123.61 10.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 73.42 110.914 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.563 ' HB3' HG22 ' A' ' 15' ' ' THR . 2.2 m-80 -115.9 85.71 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.11 110.913 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -61.14 -15.08 29.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 74.33 110.89 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.69 -32.29 67.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 54.35 110.855 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.563 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.9 t -123.86 7.54 8.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.463 . . . . 74.21 111.131 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.79 67.19 2.35 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.762 -0.732 . . . . 72.14 112.511 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -154.64 115.33 3.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.347 . . . . 65.42 110.885 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 m -136.83 162.69 32.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 60.35 110.848 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 178.87 157.8 0.52 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 64.43 110.946 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -116.61 129.24 56.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 75.23 110.881 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.608 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 73.32 110.901 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.145 0 CA-C-O 120.737 0.224 . . . . 65.41 112.354 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.411 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.6 pt -113.61 123.36 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 60.44 111.109 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.839 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.06 140.0 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 61.41 111.168 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.839 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -113.95 150.79 33.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 54.11 110.959 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.8 t -148.31 123.94 10.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 72.51 110.872 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.569 ' HB3' HG22 ' A' ' 15' ' ' THR . 2.2 m-80 -116.2 85.84 2.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 64.42 110.862 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -61.16 -15.06 29.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 72.13 110.914 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.2 mmm-85 -71.81 -32.25 67.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 74.11 110.869 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.569 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.9 t -123.85 7.48 8.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 65.51 111.079 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.77 67.09 2.4 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 72.33 112.506 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -154.61 115.36 3.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.819 0.342 . . . . 74.45 110.9 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.96 162.81 32.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 73.31 110.88 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 178.88 157.83 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 65.23 110.905 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -116.59 129.23 56.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 72.4 110.917 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.607 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 73.31 110.895 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.231 0.145 0 CA-C-O 120.73 0.221 . . . . 75.4 112.374 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.55 123.33 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 61.24 111.117 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.08 139.89 39.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 62.13 111.146 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.838 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -113.95 150.77 33.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 75.43 110.867 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.9 t -148.2 123.59 10.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 61.24 110.873 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.555 ' HB3' HG22 ' A' ' 15' ' ' THR . 2.1 m-80 -115.67 85.74 2.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 64.44 110.871 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -15.09 29.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 61.05 110.845 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -71.76 -32.21 67.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 63.4 110.872 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.555 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.9 t -123.93 7.56 8.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 70.04 111.096 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.74 67.2 2.34 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 24.14 112.489 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -154.77 115.37 3.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.369 . . . . 71.43 110.887 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.85 163.0 31.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 61.41 110.9 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 178.85 157.79 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 53.33 110.924 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.3 OUTLIER -116.55 129.22 56.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 72.22 110.871 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.606 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 73.24 110.856 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.232 0.207 0 CA-C-O 120.775 0.24 . . . . 71.24 112.4 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 pt -113.55 123.4 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 74.11 111.161 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.831 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -138.99 139.52 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 73.43 111.099 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.831 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.3 p90 -113.83 150.85 32.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.486 . . . . 75.43 110.91 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.4 t -148.22 123.33 10.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 71.05 110.878 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.568 ' HB3' HG22 ' A' ' 15' ' ' THR . 2.1 m-80 -115.54 85.77 2.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 55.11 110.91 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -15.18 29.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 75.13 110.894 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -71.67 -32.2 67.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 73.02 110.874 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.568 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.9 t -123.94 7.45 8.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 63.24 111.087 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.84 67.18 2.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.736 . . . . 62.15 112.446 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -154.68 115.2 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.877 0.37 . . . . 74.21 110.921 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -137.24 162.09 34.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 54.21 110.856 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 179.02 157.3 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 71.33 110.891 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.553 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -115.48 129.45 56.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 74.3 110.874 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.614 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 70.52 110.881 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.482 -0.247 . . . . 73.33 112.482 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -99.46 -58.19 1.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.982 0.42 . . . . 64.42 110.843 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -94.27 156.89 16.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 72.23 110.912 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.4 mtmm -116.15 79.33 8.48 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.581 0.705 . . . . 74.15 110.851 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -35.02 13.58 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.723 2.282 . . . . 72.42 112.336 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.413 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 15.7 t -134.69 110.55 11.23 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.641 0.734 . . . . 71.13 111.119 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 6' ' ' VAL . 53.9 Cg_endo -69.7 -173.6 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.727 2.284 . . . . 62.43 112.365 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 pt -113.49 123.91 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 51.42 111.109 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.814 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -137.13 136.51 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 70.21 111.138 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.814 ' N ' HD12 ' A' ' 9' ' ' ILE . 2.7 p90 -114.98 150.67 35.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.207 -0.451 . . . . 45.31 110.943 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.8 t -146.28 130.14 17.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 73.1 110.881 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.433 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.6 m-20 -106.47 87.31 2.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 75.52 110.909 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -57.6 -16.52 10.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 73.34 110.857 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -69.74 -30.7 68.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 62.14 110.88 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.433 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.6 t -130.92 8.72 4.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 74.32 111.117 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.32 70.49 0.93 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.744 -0.741 . . . . 35.21 112.5 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -155.21 116.63 4.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 72.32 110.915 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.97 170.91 12.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 51.35 110.851 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.55 156.52 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 72.51 110.9 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.515 ' CG ' ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -106.45 140.68 38.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 74.54 110.868 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.486 ' CE1' ' HD1' ' A' ' 10' ' ' TYR . 3.1 m-85 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 70.42 110.88 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.492 -0.243 . . . . 52.13 112.492 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m -121.39 -54.54 1.98 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.916 0.388 . . . . 61.44 110.854 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -124.66 142.07 51.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 51.32 110.884 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.15 79.32 2.76 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.644 0.735 . . . . 72.51 110.893 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -32.82 18.06 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.738 2.292 . . . . 63.34 112.342 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.71 110.54 11.2 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.676 0.75 . . . . 74.02 111.144 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 179.71 3.5 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.673 2.249 . . . . 72.35 112.376 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.7 pt -113.58 123.34 69.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 52.11 111.089 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.84 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.13 140.01 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 75.32 111.142 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.84 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -113.96 150.82 33.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.892 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.7 t -148.31 123.56 10.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 61.54 110.907 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.567 ' HB3' HG22 ' A' ' 15' ' ' THR . 2.1 m-80 -115.82 85.79 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 75.4 110.867 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 -61.18 -15.05 29.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 71.21 110.862 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -71.79 -32.23 67.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 53.03 110.887 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.567 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.9 t -123.81 7.51 8.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 73.35 111.137 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.74 67.18 2.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 53.04 112.498 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -154.69 115.31 3.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.338 . . . . 75.23 110.9 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.89 162.75 32.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 54.14 110.873 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 178.98 157.87 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 45.12 110.949 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -116.57 129.22 56.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 73.31 110.902 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.6 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 75.44 110.898 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.254 0 N-CA-C 112.499 -0.241 . . . . 72.34 112.499 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.2 p -138.85 -69.46 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 62.33 110.843 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -100.03 171.85 7.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 54.35 110.877 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.14 79.41 3.63 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.552 0.692 . . . . 61.23 110.857 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.86 -32.82 17.43 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.683 2.256 . . . . 74.22 112.332 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.8 110.53 11.11 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.646 0.736 . . . . 75.54 111.103 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -176.55 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.654 2.236 . . . . 73.31 112.317 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.444 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.5 pt -113.64 123.13 68.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 55.41 111.115 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.825 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.67 141.08 35.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 64.21 111.119 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.825 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.6 p90 -114.25 150.09 34.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 50.11 110.925 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 t -149.25 120.65 7.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 62.44 110.878 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.484 ' HB3' HG22 ' A' ' 15' ' ' THR . 31.4 m120 -114.41 88.31 2.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.477 . . . . 73.15 110.851 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -58.58 -17.82 24.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 65.53 110.846 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -76.26 -56.07 4.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 74.35 110.86 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.5 t -92.18 8.93 35.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 73.31 111.161 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.06 68.34 1.45 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.76 -0.733 . . . . 44.25 112.524 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -155.18 116.57 4.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.796 0.331 . . . . 74.02 110.938 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.5 m -136.03 157.06 47.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 54.22 110.846 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.411 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 3.8 tt0 178.36 158.57 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 63.34 110.932 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -117.61 129.52 55.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.12 110.842 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.594 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 75.24 110.933 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.491 -0.244 . . . . 72.43 112.491 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -118.74 -63.59 1.39 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.915 0.388 . . . . 74.43 110.874 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.03 159.31 34.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 74.25 110.872 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.64 79.36 4.27 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.527 0.68 . . . . 70.24 110.888 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -32.83 17.57 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.633 2.222 . . . . 74.3 112.33 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.8 t -134.78 110.57 11.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.691 0.758 . . . . 73.24 111.128 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -173.03 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.648 2.232 . . . . 74.12 112.345 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.5 pt -113.64 123.12 68.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 64.42 111.088 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.835 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.65 141.05 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.472 . . . . 72.14 111.135 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.835 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.6 p90 -114.23 150.12 34.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 74.45 110.914 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.3 t -149.32 120.49 7.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 75.2 110.893 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.482 ' HB3' HG22 ' A' ' 15' ' ' THR . 31.2 m120 -114.26 88.26 2.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.44 110.878 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -58.59 -17.8 24.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 72.01 110.859 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -76.15 -55.89 5.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 61.3 110.84 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.482 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.5 t -92.53 8.98 36.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 64.43 111.135 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.12 68.36 1.45 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 62.1 112.468 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -155.29 116.59 3.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 61.11 110.918 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.3 m -136.02 157.13 47.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 65.31 110.867 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.406 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 4.0 tt0 178.38 158.49 0.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 75.5 110.951 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.59 129.51 55.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 75.14 110.894 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.601 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 51.23 110.908 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.498 -0.241 . . . . 71.13 112.498 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.28 -72.04 0.65 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 50.53 110.87 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -91.96 169.65 10.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 71.54 110.92 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -121.8 79.34 40.39 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.561 0.696 . . . . 74.14 110.874 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -33.52 16.41 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.647 2.231 . . . . 64.42 112.338 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.8 t -134.68 110.58 11.25 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.662 0.744 . . . . 72.22 111.105 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 174.32 9.63 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.688 2.259 . . . . 74.23 112.396 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.5 pt -113.63 123.23 69.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.44 . . . . 55.02 111.134 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.842 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -139.56 142.03 33.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 72.34 111.14 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.842 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.5 p90 -113.84 149.8 34.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 72.35 110.887 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.82 116.95 6.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 72.42 110.898 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.42 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.7 m-80 -117.65 86.78 2.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.867 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.0 ptt85 -60.57 -16.05 33.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 74.42 110.9 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -71.97 -56.33 5.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 74.51 110.855 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.42 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.8 t -96.88 10.25 39.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 72.13 111.133 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.79 72.34 0.56 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.736 -0.745 . . . . 70.2 112.502 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -154.37 114.54 3.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.819 0.342 . . . . 42.33 110.868 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.4 t -135.33 152.65 51.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 73.12 110.899 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.42 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 3.2 tt0 175.84 159.51 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 74.24 110.89 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -119.21 129.41 54.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 73.31 110.901 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.594 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 75.44 110.901 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.472 -0.251 . . . . 72.43 112.472 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.15 -66.58 0.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.934 0.397 . . . . 72.11 110.885 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.95 171.3 7.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 73.33 110.911 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -114.02 79.35 4.76 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.585 0.707 . . . . 71.24 110.916 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -32.73 18.19 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.723 2.282 . . . . 73.22 112.358 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.81 110.61 11.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.643 0.735 . . . . 74.53 111.12 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -174.86 1.0 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.726 2.284 . . . . 74.12 112.308 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.4 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.7 pt -113.49 123.33 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 75.33 111.153 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.825 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.1 140.2 38.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 73.2 111.11 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.825 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -114.18 150.81 33.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 73.34 110.952 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.7 t -148.41 125.02 11.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 63.35 110.861 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.465 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.8 m-80 -116.23 87.12 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 73.41 110.919 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -15.79 29.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 62.32 110.895 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -44.63 66.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 75.12 110.871 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.465 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.2 t -110.27 8.53 23.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 70.43 111.163 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.79 70.24 1.02 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.737 . . . . 51.22 112.497 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 9.7 ptmt -159.34 119.91 3.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 74.41 110.879 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.58 165.19 27.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 62.23 110.887 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.4 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 3.8 tt0 178.65 157.94 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 73.12 110.93 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.06 129.42 55.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 75.35 110.837 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.595 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 73.45 110.857 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.494 -0.242 . . . . 61.14 112.494 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -131.97 -70.46 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 73.43 110.898 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -138.43 160.03 40.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 74.51 110.892 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -127.82 79.38 73.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.619 0.723 . . . . 65.2 110.902 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -33.68 16.19 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.69 2.26 . . . . 72.22 112.345 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.7 t -134.7 110.57 11.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.601 0.715 . . . . 74.43 111.133 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 173.85 10.37 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.671 2.247 . . . . 75.34 112.35 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.7 pt -113.62 123.33 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 74.14 111.126 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.841 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.07 140.19 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 74.34 111.103 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.841 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -114.21 150.81 33.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 71.23 110.882 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.6 t -148.33 125.0 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 52.12 110.913 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.478 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.8 m-80 -116.3 87.14 2.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 73.31 110.859 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -60.49 -15.71 29.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 73.14 110.881 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -70.6 -44.22 67.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 75.2 110.862 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.478 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.2 t -110.76 8.42 22.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 75.21 111.143 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.94 70.12 1.06 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.772 -0.727 . . . . 74.4 112.487 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 12.1 ptmt -159.25 119.87 3.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 74.2 110.909 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.59 165.23 27.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 73.21 110.86 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 178.63 157.96 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 53.34 110.923 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.06 129.45 56.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 74.33 110.891 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.604 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.859 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.492 -0.243 . . . . 75.12 112.492 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.57 -50.66 0.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.903 0.382 . . . . 72.42 110.839 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.5 pttt -127.89 156.84 41.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 72.43 110.935 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.93 79.34 2.6 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.529 0.68 . . . . 71.4 110.882 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -32.58 18.05 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.673 2.249 . . . . 53.32 112.338 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.77 110.55 11.15 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.63 0.728 . . . . 73.41 111.13 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -171.64 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.7 2.267 . . . . 34.13 112.323 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.414 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.6 pt -113.57 123.28 69.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 74.34 111.151 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.13 140.27 38.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 72.32 111.147 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.838 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -114.2 150.76 33.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 72.11 110.909 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.7 t -148.4 124.98 11.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 73.31 110.894 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.467 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.8 m-80 -116.35 87.06 2.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 63.54 110.882 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.34 -15.85 29.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 75.53 110.856 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.5 -45.21 66.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 71.4 110.836 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.1 t -109.63 8.39 24.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 61.44 111.098 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.9 71.02 0.79 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.798 -0.715 . . . . 35.32 112.476 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 42.0 pttt -160.29 120.21 2.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 52.41 110.878 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.76 165.1 27.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 43.45 110.868 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 178.76 158.04 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 63.45 110.905 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.13 129.39 55.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 73.44 110.877 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.594 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.931 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.472 -0.251 . . . . 53.52 112.472 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.71 -56.25 1.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.982 0.42 . . . . 60.41 110.853 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -134.28 153.64 51.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 73.31 110.903 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -113.47 79.34 4.03 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.553 0.692 . . . . 71.54 110.89 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -32.48 18.43 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.693 2.262 . . . . 35.53 112.303 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.67 110.58 11.25 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.608 0.718 . . . . 61.32 111.109 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -172.17 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.681 2.254 . . . . 72.3 112.317 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.417 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.6 pt -113.57 123.32 69.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 54.13 111.113 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.824 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.11 140.28 38.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 75.04 111.15 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.824 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -114.2 150.8 33.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 65.14 110.923 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.5 t -148.41 124.5 10.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 72.14 110.889 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.464 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.8 m-80 -115.95 86.95 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 60.32 110.87 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -60.47 -15.81 30.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 75.1 110.821 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -70.41 -44.09 68.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 74.13 110.854 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.464 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.1 t -110.77 8.23 22.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 74.52 111.151 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.21 70.72 0.88 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.698 -0.763 . . . . 72.11 112.519 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 8.4 pttp -160.12 120.14 2.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.82 0.343 . . . . 70.22 110.932 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.75 165.16 27.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 73.04 110.824 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.401 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 4.2 tt0 178.76 157.95 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 74.33 110.892 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.02 129.43 56.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 74.41 110.89 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.591 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.453 . . . . 64.22 110.899 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.52 -0.232 . . . . 64.23 112.52 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.27 -64.67 1.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.945 0.403 . . . . 75.34 110.851 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.0 mttt -116.82 160.17 21.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 71.12 110.924 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.67 79.38 16.25 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.562 0.696 . . . . 44.11 110.895 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -32.49 18.4 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.73 2.287 . . . . 73.34 112.331 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.74 110.56 11.17 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.645 0.736 . . . . 74.43 111.126 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -171.16 0.45 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.656 2.238 . . . . 62.25 112.346 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.7 pt -113.6 123.39 69.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 70.43 111.115 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -138.89 139.62 40.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 71.21 111.126 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.838 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.3 p90 -113.97 150.88 33.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 63.43 110.906 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.2 t -148.32 123.76 10.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 74.42 110.909 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.475 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.7 m-80 -115.15 87.07 2.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 72.31 110.896 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -60.38 -15.76 29.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 72.21 110.871 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -70.49 -43.79 69.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 72.54 110.893 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.475 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.3 t -111.14 8.23 21.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 70.35 111.171 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.13 70.59 0.91 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.76 . . . . 74.52 112.481 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -159.74 119.74 2.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 73.34 110.882 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -138.98 164.16 30.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 72.45 110.909 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 178.69 157.32 0.48 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 74.2 110.903 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.549 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -115.6 129.57 56.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.52 110.858 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.595 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.14 110.898 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.54 -0.224 . . . . 65.13 112.54 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -130.6 -68.49 0.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.895 0.379 . . . . 54.11 110.883 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -130.8 171.1 13.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 54.24 110.91 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -111.99 79.33 2.64 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.58 0.705 . . . . 65.13 110.905 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -33.52 16.38 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.683 2.255 . . . . 55.5 112.356 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.7 t -134.76 110.55 11.15 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.72 . . . . 73.12 111.103 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -174.63 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.704 2.269 . . . . 74.22 112.375 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.446 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.5 pt -113.54 123.06 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 41.23 111.159 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.73 141.11 35.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 71.5 111.133 179.837 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.838 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.6 p90 -114.24 150.08 34.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 73.41 110.91 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.1 t -149.35 120.48 7.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 60.1 110.899 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.472 ' HB3' HG22 ' A' ' 15' ' ' THR . 30.6 m120 -114.48 88.37 2.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 73.34 110.917 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -58.63 -17.81 25.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 64.41 110.835 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -56.18 4.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 74.35 110.895 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.472 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.5 t -92.15 8.86 36.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 43.34 111.128 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.17 68.44 1.42 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.768 -0.729 . . . . 63.23 112.455 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.6 mtpp -155.26 116.56 3.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.338 . . . . 64.34 110.855 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.9 m -136.11 157.01 47.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 70.21 110.861 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.404 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 2.1 tt0 178.29 158.54 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 55.51 110.948 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.508 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.6 129.53 55.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 54.43 110.869 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.598 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 65.32 110.869 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.446 -0.262 . . . . 72.53 112.446 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.0 t -105.19 -65.92 1.01 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.899 0.38 . . . . 43.12 110.817 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.49 162.41 13.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 62.11 110.892 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.0 mttp -127.63 79.35 73.61 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.608 0.718 . . . . 75.22 110.917 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -38.49 7.72 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.719 2.279 . . . . 75.34 112.314 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.406 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 15.7 t -134.73 110.61 11.19 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.595 0.712 . . . . 63.03 111.104 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 6' ' ' VAL . 53.9 Cg_endo -69.77 -170.96 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.703 2.268 . . . . 53.54 112.328 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 pt -113.45 123.83 69.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 74.33 111.139 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.818 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -137.11 135.85 47.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 55.25 111.116 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.818 ' N ' HD12 ' A' ' 9' ' ' ILE . 2.8 p90 -115.14 150.83 35.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 63.42 110.95 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.0 t -145.12 133.9 22.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 50.02 110.888 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.469 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.5 m-20 -107.99 88.15 2.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 63.43 110.875 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.5 mtt180 -57.73 -16.46 11.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 75.53 110.878 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.9 mmt-85 -70.46 -31.01 67.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 72.21 110.874 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.469 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.0 t -129.35 8.47 5.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 63.21 111.137 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.47 74.81 0.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.719 -0.753 . . . . 33.42 112.516 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.416 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 3.3 pttt -162.22 120.9 2.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 74.04 110.905 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.95 170.99 12.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 62.52 110.902 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -176.66 154.84 1.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 60.01 110.952 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.509 ' CG ' ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -105.34 140.79 37.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 71.25 110.908 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.493 ' CE1' ' HD2' ' A' ' 10' ' ' TYR . 3.4 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 65.02 110.883 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.452 -0.259 . . . . 65.44 112.452 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -121.74 -65.0 1.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.946 0.403 . . . . 72.23 110.879 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -98.06 173.54 6.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 75.24 110.867 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -112.3 79.39 2.9 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.639 0.733 . . . . 74.41 110.916 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -32.58 18.39 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.696 2.264 . . . . 74.11 112.36 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.5 t -134.71 110.56 11.21 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.643 0.735 . . . . 41.44 111.14 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -174.94 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.689 2.26 . . . . 74.14 112.317 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.406 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.7 pt -113.62 123.13 68.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 74.21 111.131 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.829 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.37 140.7 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.11 111.134 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.829 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.6 p90 -114.36 150.41 34.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 74.52 110.898 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.7 t -149.25 123.66 9.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 73.4 110.879 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.528 ' HB3' HG22 ' A' ' 15' ' ' THR . 33.7 m120 -113.57 88.82 2.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 71.32 110.884 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.8 mmm-85 -58.55 -17.72 23.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 74.31 110.896 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.27 -56.92 4.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 73.34 110.857 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.528 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.3 t -90.14 7.85 35.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 71.3 111.18 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.94 73.55 0.35 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.736 -0.745 . . . . 62.23 112.474 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.418 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -166.26 123.54 1.38 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.845 0.355 . . . . 74.55 110.882 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 m -139.19 165.26 27.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 44.1 110.885 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.402 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 3.7 tt0 178.28 158.2 0.47 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 74.1 110.894 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -117.8 129.74 55.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 73.32 110.856 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.591 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 72.25 110.872 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.481 -0.248 . . . . 61.25 112.481 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.3 t -122.65 -69.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.927 0.394 . . . . 72.42 110.844 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -109.02 158.72 17.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.107 -0.497 . . . . 55.04 110.903 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -125.43 79.32 67.04 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.584 0.707 . . . . 74.14 110.898 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -33.11 17.23 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.721 2.281 . . . . 70.02 112.316 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.7 t -134.77 110.58 11.14 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.59 0.709 . . . . 42.12 111.14 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -178.2 2.24 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.63 2.22 . . . . 75.22 112.332 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.41 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.6 pt -113.59 123.16 68.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 74.0 111.121 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.847 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.42 140.71 36.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 65.15 111.121 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.847 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.6 p90 -114.48 150.39 34.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 71.42 110.921 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.4 t -149.2 123.94 9.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 73.24 110.877 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.529 ' HB3' HG22 ' A' ' 15' ' ' THR . 33.7 m120 -113.57 88.85 2.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 72.41 110.875 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -58.53 -17.74 23.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 54.44 110.845 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.9 mtt180 -76.22 -56.79 4.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 74.44 110.872 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.529 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.3 t -90.33 7.93 36.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 72.34 111.126 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.8 73.31 0.37 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.759 -0.734 . . . . 65.42 112.524 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 43.6 pttt -166.18 123.46 1.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 63.31 110.883 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.6 m -139.09 165.74 26.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 64.31 110.927 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 178.27 158.17 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 72.25 110.883 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -117.7 129.65 55.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 75.41 110.842 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.602 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 74.4 110.926 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.495 -0.242 . . . . 75.21 112.495 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.38 -71.91 0.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.97 0.414 . . . . 51.32 110.857 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.61 159.98 15.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 53.31 110.893 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.39 79.31 2.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.603 0.716 . . . . 74.14 110.873 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -34.46 14.62 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.709 2.272 . . . . 75.14 112.316 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.65 110.55 11.26 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.637 0.732 . . . . 71.21 111.117 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 179.39 3.69 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.699 2.266 . . . . 74.24 112.342 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.3 pt -113.65 123.24 69.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 75.51 111.164 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.835 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -139.63 142.17 33.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 64.21 111.125 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.835 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -113.68 149.58 34.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.485 . . . . 71.53 110.897 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.91 116.99 6.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 70.53 110.896 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.415 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.5 m-80 -116.83 86.32 2.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 73.4 110.878 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -60.61 -16.13 35.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 72.23 110.865 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -53.72 13.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 74.33 110.865 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.415 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.6 t -100.22 10.0 41.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.449 . . . . 72.3 111.129 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.56 72.46 0.55 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.749 -0.738 . . . . 44.34 112.517 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -154.38 114.35 3.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.814 0.34 . . . . 73.4 110.935 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.9 t -134.1 153.66 51.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 75.43 110.887 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 176.09 157.22 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 71.51 110.917 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -118.25 128.94 55.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 74.23 110.907 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.594 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 64.31 110.847 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.478 -0.249 . . . . 53.43 112.478 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.53 -59.41 1.8 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.969 0.414 . . . . 54.42 110.891 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.9 pttt -108.32 147.77 31.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.509 . . . . 64.33 110.875 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -131.26 79.34 70.55 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.532 0.682 . . . . 60.45 110.853 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -47.24 0.96 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.683 2.255 . . . . 71.42 112.361 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.59 ' O ' HG13 ' A' ' 6' ' ' VAL . 9.3 p -100.56 110.25 59.79 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.61 0.719 . . . . 72.23 111.101 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 -178.76 2.53 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.657 2.238 . . . . 70.21 112.322 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 pt -113.4 124.0 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 71.24 111.148 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.836 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -137.39 136.92 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 74.54 111.101 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.836 ' N ' HD12 ' A' ' 9' ' ' ILE . 2.7 p90 -115.24 150.67 35.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 71.31 110.924 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.6 t -146.37 130.27 17.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 70.52 110.87 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.443 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.6 m-20 -106.76 87.27 2.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 53.32 110.866 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.67 -16.43 10.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 71.33 110.867 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -69.85 -30.71 68.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 71.21 110.861 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.443 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.6 t -130.85 8.73 4.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 72.44 111.126 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.36 70.51 0.93 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.779 -0.724 . . . . 65.14 112.462 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.5 mttm -155.21 116.61 4.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.797 0.332 . . . . 53.22 110.839 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.02 171.08 12.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 54.45 110.895 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -179.54 156.55 0.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 73.01 110.905 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.516 ' CG ' ' HB ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -106.63 140.5 39.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 75.14 110.898 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.496 ' CE1' ' HD2' ' A' ' 10' ' ' TYR . 3.1 m-85 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.45 110.913 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.503 -0.239 . . . . 75.11 112.503 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.63 -67.3 0.76 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.964 0.412 . . . . 71.52 110.867 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.88 156.26 17.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.506 . . . . 72.44 110.868 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -121.8 79.37 40.35 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.537 0.684 . . . . 73.11 110.885 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -43.93 2.39 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.714 2.276 . . . . 43.33 112.328 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.586 ' O ' HG13 ' A' ' 6' ' ' VAL . 9.3 p -100.5 110.21 59.57 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.629 0.728 . . . . 64.24 111.172 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 178.39 4.63 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.715 2.277 . . . . 45.03 112.324 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.402 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.8 pt -113.55 123.33 69.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 74.41 111.155 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.828 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.04 140.01 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.457 . . . . 65.44 111.091 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.828 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -114.0 150.77 33.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 74.14 110.877 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.7 t -148.27 123.61 10.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 73.42 110.914 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.563 ' HB3' HG22 ' A' ' 15' ' ' THR . 2.2 m-80 -115.9 85.71 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.11 110.913 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -61.14 -15.08 29.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 74.33 110.89 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.69 -32.29 67.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 54.35 110.855 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.563 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.9 t -123.86 7.54 8.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.463 . . . . 74.21 111.131 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.79 67.19 2.35 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.762 -0.732 . . . . 72.14 112.511 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -154.64 115.33 3.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.347 . . . . 65.42 110.885 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 m -136.83 162.69 32.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 60.35 110.848 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 178.87 157.8 0.52 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 64.43 110.946 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -116.61 129.24 56.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 75.23 110.881 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.608 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 73.32 110.901 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.464 -0.255 . . . . 72.44 112.464 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.24 -59.3 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.971 0.415 . . . . 75.34 110.909 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -132.88 130.64 39.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 73.42 110.866 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.2 79.35 6.46 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.57 0.7 . . . . 65.12 110.855 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -43.64 2.55 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.626 2.217 . . . . 73.32 112.36 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.588 ' O ' HG13 ' A' ' 6' ' ' VAL . 9.3 p -100.52 110.22 59.62 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.644 0.735 . . . . 74.14 111.154 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -178.34 2.31 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.698 2.266 . . . . 65.41 112.354 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.411 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.6 pt -113.61 123.36 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 60.44 111.109 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.839 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.06 140.0 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 61.41 111.168 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.839 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -113.95 150.79 33.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 54.11 110.959 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.8 t -148.31 123.94 10.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 72.51 110.872 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.569 ' HB3' HG22 ' A' ' 15' ' ' THR . 2.2 m-80 -116.2 85.84 2.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 64.42 110.862 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -61.16 -15.06 29.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 72.13 110.914 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.2 mmm-85 -71.81 -32.25 67.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 74.11 110.869 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.569 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.9 t -123.85 7.48 8.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 65.51 111.079 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.77 67.09 2.4 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 72.33 112.506 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -154.61 115.36 3.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.819 0.342 . . . . 74.45 110.9 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.96 162.81 32.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 73.31 110.88 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 178.88 157.83 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 65.23 110.905 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -116.59 129.23 56.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 72.4 110.917 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.607 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 73.31 110.895 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.479 -0.248 . . . . 71.13 112.479 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 t -127.94 -53.61 1.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.977 0.418 . . . . 74.42 110.847 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.97 144.45 35.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 71.33 110.878 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -116.35 79.42 8.99 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.583 0.706 . . . . 73.12 110.894 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -47.45 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.678 2.252 . . . . 73.2 112.342 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 6' ' ' VAL . 9.3 p -100.57 110.19 59.61 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.581 0.705 . . . . 62.31 111.157 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -177.25 1.79 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.655 2.236 . . . . 75.4 112.374 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.55 123.33 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 61.24 111.117 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.08 139.89 39.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 62.13 111.146 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.838 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -113.95 150.77 33.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 75.43 110.867 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.9 t -148.2 123.59 10.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 61.24 110.873 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.555 ' HB3' HG22 ' A' ' 15' ' ' THR . 2.1 m-80 -115.67 85.74 2.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 64.44 110.871 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -15.09 29.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 61.05 110.845 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -71.76 -32.21 67.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 63.4 110.872 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.555 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.9 t -123.93 7.56 8.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 70.04 111.096 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.74 67.2 2.34 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 24.14 112.489 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -154.77 115.37 3.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.369 . . . . 71.43 110.887 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.85 163.0 31.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 61.41 110.9 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 178.85 157.79 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 53.33 110.924 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.3 OUTLIER -116.55 129.22 56.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 72.22 110.871 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.606 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 73.24 110.856 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.488 -0.245 . . . . 61.15 112.488 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -135.22 -69.08 0.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.866 0.365 . . . . 72.51 110.875 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.95 161.55 28.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 75.35 110.933 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.1 mttt -117.71 79.28 12.75 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.575 0.703 . . . . 74.21 110.935 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -45.82 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.703 2.269 . . . . 71.54 112.363 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 6' ' ' VAL . 9.3 p -100.58 110.21 59.72 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.65 0.738 . . . . 72.33 111.101 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 6' ' ' VAL . 54.3 Cg_endo -69.74 169.41 18.95 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.682 2.255 . . . . 71.24 112.4 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 pt -113.55 123.4 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 74.11 111.161 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.831 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -138.99 139.52 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 73.43 111.099 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.831 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.3 p90 -113.83 150.85 32.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.486 . . . . 75.43 110.91 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.4 t -148.22 123.33 10.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 71.05 110.878 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.568 ' HB3' HG22 ' A' ' 15' ' ' THR . 2.1 m-80 -115.54 85.77 2.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 55.11 110.91 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -15.18 29.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 75.13 110.894 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -71.67 -32.2 67.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 73.02 110.874 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.568 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.9 t -123.94 7.45 8.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 63.24 111.087 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.84 67.18 2.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.736 . . . . 62.15 112.446 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -154.68 115.2 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.877 0.37 . . . . 74.21 110.921 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -137.24 162.09 34.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 54.21 110.856 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 179.02 157.3 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 71.33 110.891 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.553 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -115.48 129.45 56.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 74.3 110.874 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.614 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 70.52 110.881 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.149 0 CA-C-O 120.773 0.239 . . . . 62.43 112.365 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 pt -113.49 123.91 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 51.42 111.109 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.814 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -137.13 136.51 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 70.21 111.138 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.814 ' N ' HD12 ' A' ' 9' ' ' ILE . 2.7 p90 -114.98 150.67 35.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.207 -0.451 . . . . 45.31 110.943 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.8 t -146.28 130.14 17.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 73.1 110.881 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.433 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.6 m-20 -106.47 87.31 2.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 75.52 110.909 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -57.6 -16.52 10.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 73.34 110.857 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -69.74 -30.7 68.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 62.14 110.88 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.433 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.6 t -130.92 8.72 4.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 74.32 111.117 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.32 70.49 0.93 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.744 -0.741 . . . . 35.21 112.5 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -155.21 116.63 4.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 72.32 110.915 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.97 170.91 12.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 51.35 110.851 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.55 156.52 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 72.51 110.9 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.515 ' CG ' ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -106.45 140.68 38.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 74.54 110.868 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.486 ' CE1' ' HD1' ' A' ' 10' ' ' TYR . 3.1 m-85 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 70.42 110.88 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.231 0.156 0 CA-C-O 120.737 0.224 . . . . 72.35 112.376 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.7 pt -113.58 123.34 69.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 52.11 111.089 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.84 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.13 140.01 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 75.32 111.142 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.84 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -113.96 150.82 33.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.892 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.7 t -148.31 123.56 10.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 61.54 110.907 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.567 ' HB3' HG22 ' A' ' 15' ' ' THR . 2.1 m-80 -115.82 85.79 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 75.4 110.867 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 -61.18 -15.05 29.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 71.21 110.862 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -71.79 -32.23 67.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 53.03 110.887 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.567 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.9 t -123.81 7.51 8.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 73.35 111.137 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.74 67.18 2.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 53.04 112.498 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -154.69 115.31 3.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.338 . . . . 75.23 110.9 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.89 162.75 32.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 54.14 110.873 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 178.98 157.87 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 45.12 110.949 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -116.57 129.22 56.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 73.31 110.902 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.6 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 75.44 110.898 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.148 0 CA-C-O 120.797 0.249 . . . . 73.31 112.317 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.444 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.5 pt -113.64 123.13 68.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 55.41 111.115 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.825 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.67 141.08 35.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 64.21 111.119 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.825 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.6 p90 -114.25 150.09 34.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 50.11 110.925 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 t -149.25 120.65 7.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 62.44 110.878 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.484 ' HB3' HG22 ' A' ' 15' ' ' THR . 31.4 m120 -114.41 88.31 2.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.477 . . . . 73.15 110.851 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -58.58 -17.82 24.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 65.53 110.846 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -76.26 -56.07 4.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 74.35 110.86 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.5 t -92.18 8.93 35.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 73.31 111.161 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.06 68.34 1.45 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.76 -0.733 . . . . 44.25 112.524 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -155.18 116.57 4.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.796 0.331 . . . . 74.02 110.938 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.5 m -136.03 157.06 47.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 54.22 110.846 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.411 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 1.7 tt0 178.36 158.57 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 63.34 110.932 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -117.61 129.52 55.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.12 110.842 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.594 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 75.24 110.933 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.81 0.254 . . . . 74.12 112.345 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.5 pt -113.64 123.12 68.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 64.42 111.088 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.835 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.65 141.05 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.472 . . . . 72.14 111.135 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.835 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.6 p90 -114.23 150.12 34.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 74.45 110.914 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.3 t -149.32 120.49 7.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 75.2 110.893 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.482 ' HB3' HG22 ' A' ' 15' ' ' THR . 31.2 m120 -114.26 88.26 2.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.44 110.878 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -58.59 -17.8 24.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 72.01 110.859 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -76.15 -55.89 5.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 61.3 110.84 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.482 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.5 t -92.53 8.98 36.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 64.43 111.135 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.12 68.36 1.45 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 62.1 112.468 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -155.29 116.59 3.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 61.11 110.918 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.3 m -136.02 157.13 47.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 65.31 110.867 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.406 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 4.0 tt0 178.38 158.49 0.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 75.5 110.951 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.59 129.51 55.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 75.14 110.894 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.601 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 51.23 110.908 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.194 0 CA-C-O 120.752 0.23 . . . . 74.23 112.396 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.5 pt -113.63 123.23 69.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.44 . . . . 55.02 111.134 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.842 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -139.56 142.03 33.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 72.34 111.14 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.842 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.5 p90 -113.84 149.8 34.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 72.35 110.887 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.82 116.95 6.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 72.42 110.898 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.42 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.7 m-80 -117.65 86.78 2.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.867 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.0 ptt85 -60.57 -16.05 33.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 74.42 110.9 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -71.97 -56.33 5.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 74.51 110.855 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.42 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.8 t -96.88 10.25 39.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 72.13 111.133 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.79 72.34 0.56 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.736 -0.745 . . . . 70.2 112.502 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -154.37 114.54 3.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.819 0.342 . . . . 42.33 110.868 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.4 t -135.33 152.65 51.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 73.12 110.899 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.42 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 3.2 tt0 175.84 159.51 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 74.24 110.89 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -119.21 129.41 54.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 73.31 110.901 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.594 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 75.44 110.901 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.768 0.237 . . . . 74.12 112.308 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.4 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.7 pt -113.49 123.33 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 75.33 111.153 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.825 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.1 140.2 38.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 73.2 111.11 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.825 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -114.18 150.81 33.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 73.34 110.952 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.7 t -148.41 125.02 11.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 63.35 110.861 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.465 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.8 m-80 -116.23 87.12 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 73.41 110.919 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -15.79 29.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 62.32 110.895 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -44.63 66.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 75.12 110.871 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.465 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.2 t -110.27 8.53 23.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 70.43 111.163 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.79 70.24 1.02 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.737 . . . . 51.22 112.497 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 9.7 ptmt -159.34 119.91 3.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 74.41 110.879 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.58 165.19 27.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 62.23 110.887 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.4 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 1.3 tt0 178.65 157.94 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 73.12 110.93 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.06 129.42 55.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 75.35 110.837 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.595 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 73.45 110.857 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.769 0.237 . . . . 75.34 112.35 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.7 pt -113.62 123.33 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 74.14 111.126 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.841 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.07 140.19 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 74.34 111.103 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.841 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -114.21 150.81 33.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 71.23 110.882 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.6 t -148.33 125.0 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 52.12 110.913 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.478 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.8 m-80 -116.3 87.14 2.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 73.31 110.859 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -60.49 -15.71 29.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 73.14 110.881 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -70.6 -44.22 67.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 75.2 110.862 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.478 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.2 t -110.76 8.42 22.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 75.21 111.143 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.94 70.12 1.06 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.772 -0.727 . . . . 74.4 112.487 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 12.1 ptmt -159.25 119.87 3.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 74.2 110.909 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.59 165.23 27.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 73.21 110.86 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 178.63 157.96 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 53.34 110.923 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.06 129.45 56.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 74.33 110.891 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.604 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.859 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.156 0 CA-C-O 120.767 0.236 . . . . 34.13 112.323 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.414 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.6 pt -113.57 123.28 69.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 74.34 111.151 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.13 140.27 38.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 72.32 111.147 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.838 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -114.2 150.76 33.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 72.11 110.909 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.7 t -148.4 124.98 11.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 73.31 110.894 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.467 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.8 m-80 -116.35 87.06 2.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 63.54 110.882 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.34 -15.85 29.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 75.53 110.856 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.5 -45.21 66.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 71.4 110.836 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.1 t -109.63 8.39 24.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 61.44 111.098 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.9 71.02 0.79 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.798 -0.715 . . . . 35.32 112.476 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 42.0 pttt -160.29 120.21 2.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 52.41 110.878 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.76 165.1 27.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 43.45 110.868 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 178.76 158.04 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 63.45 110.905 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.13 129.39 55.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 73.44 110.877 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.594 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.931 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.757 0.232 . . . . 72.3 112.317 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.417 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.6 pt -113.57 123.32 69.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 54.13 111.113 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.824 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.11 140.28 38.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 75.04 111.15 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.824 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -114.2 150.8 33.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 65.14 110.923 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.5 t -148.41 124.5 10.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 72.14 110.889 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.464 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.8 m-80 -115.95 86.95 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 60.32 110.87 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -60.47 -15.81 30.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 75.1 110.821 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -70.41 -44.09 68.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 74.13 110.854 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.464 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.1 t -110.77 8.23 22.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 74.52 111.151 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.21 70.72 0.88 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.698 -0.763 . . . . 72.11 112.519 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 8.4 pttp -160.12 120.14 2.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.82 0.343 . . . . 70.22 110.932 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.75 165.16 27.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 73.04 110.824 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.401 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 4.2 tt0 178.76 157.95 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 74.33 110.892 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.02 129.43 56.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 74.41 110.89 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.591 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.453 . . . . 64.22 110.899 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.143 0 CA-C-O 120.757 0.232 . . . . 62.25 112.346 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.7 pt -113.6 123.39 69.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 70.43 111.115 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -138.89 139.62 40.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 71.21 111.126 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.838 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.3 p90 -113.97 150.88 33.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 63.43 110.906 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.2 t -148.32 123.76 10.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 74.42 110.909 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.475 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.7 m-80 -115.15 87.07 2.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 72.31 110.896 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -60.38 -15.76 29.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 72.21 110.871 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -70.49 -43.79 69.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 72.54 110.893 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.475 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.3 t -111.14 8.23 21.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 70.35 111.171 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.13 70.59 0.91 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.76 . . . . 74.52 112.481 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -159.74 119.74 2.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 73.34 110.882 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -138.98 164.16 30.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 72.45 110.909 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 178.69 157.32 0.48 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 74.2 110.903 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.549 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -115.6 129.57 56.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.52 110.858 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.595 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.14 110.898 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.149 0 CA-C-O 120.758 0.233 . . . . 74.22 112.375 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.446 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.5 pt -113.54 123.06 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 41.23 111.159 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.73 141.11 35.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 71.5 111.133 179.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.838 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.6 p90 -114.24 150.08 34.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 73.41 110.91 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.1 t -149.35 120.48 7.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 60.1 110.899 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.472 ' HB3' HG22 ' A' ' 15' ' ' THR . 30.6 m120 -114.48 88.37 2.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 73.34 110.917 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -58.63 -17.81 25.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 64.41 110.835 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -56.18 4.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 74.35 110.895 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.472 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.5 t -92.15 8.86 36.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 43.34 111.128 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.17 68.44 1.42 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.768 -0.729 . . . . 63.23 112.455 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.6 mtpp -155.26 116.56 3.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.338 . . . . 64.34 110.855 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.9 m -136.11 157.01 47.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 70.21 110.861 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.404 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 2.1 tt0 178.29 158.54 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 55.51 110.948 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.508 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.6 129.53 55.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 54.43 110.869 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.598 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 65.32 110.869 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.211 0 CA-C-O 120.754 0.231 . . . . 53.54 112.328 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 pt -113.45 123.83 69.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 74.33 111.139 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.818 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -137.11 135.85 47.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 55.25 111.116 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.818 ' N ' HD12 ' A' ' 9' ' ' ILE . 2.8 p90 -115.14 150.83 35.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 63.42 110.95 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.0 t -145.12 133.9 22.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 50.02 110.888 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.469 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.5 m-20 -107.99 88.15 2.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 63.43 110.875 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.5 mtt180 -57.73 -16.46 11.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 75.53 110.878 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.9 mmt-85 -70.46 -31.01 67.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 72.21 110.874 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.469 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.0 t -129.35 8.47 5.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 63.21 111.137 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.47 74.81 0.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.719 -0.753 . . . . 33.42 112.516 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.416 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 3.3 pttt -162.22 120.9 2.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 74.04 110.905 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.95 170.99 12.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 62.52 110.902 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -176.66 154.84 1.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 60.01 110.952 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.509 ' CG ' ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -105.34 140.79 37.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 71.25 110.908 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.493 ' CE1' ' HD2' ' A' ' 10' ' ' TYR . 3.4 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 65.02 110.883 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.231 0.138 0 CA-C-O 120.751 0.23 . . . . 74.14 112.317 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.406 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.7 pt -113.62 123.13 68.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 74.21 111.131 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.829 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.37 140.7 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.11 111.134 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.829 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.6 p90 -114.36 150.41 34.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 74.52 110.898 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.7 t -149.25 123.66 9.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 73.4 110.879 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.528 ' HB3' HG22 ' A' ' 15' ' ' THR . 33.7 m120 -113.57 88.82 2.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 71.32 110.884 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.8 mmm-85 -58.55 -17.72 23.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 74.31 110.896 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.27 -56.92 4.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 73.34 110.857 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.528 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.3 t -90.14 7.85 35.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 71.3 111.18 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.94 73.55 0.35 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.736 -0.745 . . . . 62.23 112.474 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.418 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -166.26 123.54 1.38 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.845 0.355 . . . . 74.55 110.882 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 m -139.19 165.26 27.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 44.1 110.885 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.402 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 1.7 tt0 178.28 158.2 0.47 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 74.1 110.894 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -117.8 129.74 55.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 73.32 110.856 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.591 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 72.25 110.872 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.771 0.238 . . . . 75.22 112.332 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.41 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.6 pt -113.59 123.16 68.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 74.0 111.121 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.847 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.42 140.71 36.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 65.15 111.121 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.847 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.6 p90 -114.48 150.39 34.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 71.42 110.921 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.4 t -149.2 123.94 9.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 73.24 110.877 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.529 ' HB3' HG22 ' A' ' 15' ' ' THR . 33.7 m120 -113.57 88.85 2.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 72.41 110.875 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -58.53 -17.74 23.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 54.44 110.845 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.9 mtt180 -76.22 -56.79 4.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 74.44 110.872 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.529 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.3 t -90.33 7.93 36.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 72.34 111.126 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.8 73.31 0.37 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.759 -0.734 . . . . 65.42 112.524 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 43.6 pttt -166.18 123.46 1.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 63.31 110.883 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.6 m -139.09 165.74 26.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 64.31 110.927 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 178.27 158.17 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 72.25 110.883 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -117.7 129.65 55.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 75.41 110.842 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.602 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 74.4 110.926 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.823 0.26 . . . . 74.24 112.342 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.3 pt -113.65 123.24 69.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 75.51 111.164 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.835 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -139.63 142.17 33.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 64.21 111.125 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.835 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -113.68 149.58 34.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.485 . . . . 71.53 110.897 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.91 116.99 6.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 70.53 110.896 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.415 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.5 m-80 -116.83 86.32 2.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 73.4 110.878 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -60.61 -16.13 35.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 72.23 110.865 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -53.72 13.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 74.33 110.865 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.415 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.6 t -100.22 10.0 41.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.449 . . . . 72.3 111.129 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.56 72.46 0.55 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.749 -0.738 . . . . 44.34 112.517 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -154.38 114.35 3.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.814 0.34 . . . . 73.4 110.935 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.9 t -134.1 153.66 51.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 75.43 110.887 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 176.09 157.22 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 71.51 110.917 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -118.25 128.94 55.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 74.23 110.907 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.594 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 64.31 110.847 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.171 0 CA-C-O 120.783 0.243 . . . . 70.21 112.322 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 pt -113.4 124.0 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 71.24 111.148 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.836 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -137.39 136.92 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 74.54 111.101 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.836 ' N ' HD12 ' A' ' 9' ' ' ILE . 2.7 p90 -115.24 150.67 35.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 71.31 110.924 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.6 t -146.37 130.27 17.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 70.52 110.87 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.443 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.6 m-20 -106.76 87.27 2.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 53.32 110.866 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.67 -16.43 10.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 71.33 110.867 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -69.85 -30.71 68.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 71.21 110.861 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.443 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.6 t -130.85 8.73 4.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 72.44 111.126 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.36 70.51 0.93 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.779 -0.724 . . . . 65.14 112.462 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.5 mttm -155.21 116.61 4.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.797 0.332 . . . . 53.22 110.839 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.02 171.08 12.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 54.45 110.895 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -179.54 156.55 0.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 73.01 110.905 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.516 ' CG ' ' HB ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -106.63 140.5 39.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 75.14 110.898 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.496 ' CE1' ' HD2' ' A' ' 10' ' ' TYR . 3.1 m-85 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.45 110.913 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.747 0.228 . . . . 45.03 112.324 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.402 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.8 pt -113.55 123.33 69.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 74.41 111.155 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.828 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.04 140.01 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.457 . . . . 65.44 111.091 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.828 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -114.0 150.77 33.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 74.14 110.877 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.7 t -148.27 123.61 10.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 73.42 110.914 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.563 ' HB3' HG22 ' A' ' 15' ' ' THR . 2.2 m-80 -115.9 85.71 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.11 110.913 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -61.14 -15.08 29.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 74.33 110.89 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.69 -32.29 67.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 54.35 110.855 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.563 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.9 t -123.86 7.54 8.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.463 . . . . 74.21 111.131 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.79 67.19 2.35 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.762 -0.732 . . . . 72.14 112.511 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -154.64 115.33 3.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.347 . . . . 65.42 110.885 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 m -136.83 162.69 32.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 60.35 110.848 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 178.87 157.8 0.52 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 64.43 110.946 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -116.61 129.24 56.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 75.23 110.881 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.608 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 73.32 110.901 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.145 0 CA-C-O 120.737 0.224 . . . . 65.41 112.354 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.411 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.6 pt -113.61 123.36 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 60.44 111.109 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.839 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.06 140.0 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 61.41 111.168 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.839 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -113.95 150.79 33.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 54.11 110.959 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.8 t -148.31 123.94 10.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 72.51 110.872 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.569 ' HB3' HG22 ' A' ' 15' ' ' THR . 2.2 m-80 -116.2 85.84 2.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 64.42 110.862 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -61.16 -15.06 29.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 72.13 110.914 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.2 mmm-85 -71.81 -32.25 67.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 74.11 110.869 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.569 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.9 t -123.85 7.48 8.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 65.51 111.079 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.77 67.09 2.4 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 72.33 112.506 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -154.61 115.36 3.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.819 0.342 . . . . 74.45 110.9 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.96 162.81 32.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 73.31 110.88 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 178.88 157.83 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 65.23 110.905 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -116.59 129.23 56.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 72.4 110.917 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.607 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 73.31 110.895 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.231 0.145 0 CA-C-O 120.73 0.221 . . . . 75.4 112.374 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.55 123.33 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 61.24 111.117 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.08 139.89 39.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 62.13 111.146 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.838 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -113.95 150.77 33.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 75.43 110.867 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.9 t -148.2 123.59 10.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 61.24 110.873 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.555 ' HB3' HG22 ' A' ' 15' ' ' THR . 2.1 m-80 -115.67 85.74 2.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 64.44 110.871 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -15.09 29.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 61.05 110.845 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -71.76 -32.21 67.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 63.4 110.872 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.555 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.9 t -123.93 7.56 8.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 70.04 111.096 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.74 67.2 2.34 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 24.14 112.489 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -154.77 115.37 3.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.369 . . . . 71.43 110.887 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.85 163.0 31.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 61.41 110.9 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 178.85 157.79 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 53.33 110.924 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.3 OUTLIER -116.55 129.22 56.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 72.22 110.871 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.606 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 73.24 110.856 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.232 0.207 0 CA-C-O 120.775 0.24 . . . . 71.24 112.4 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 pt -113.55 123.4 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 74.11 111.161 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.831 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -138.99 139.52 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 73.43 111.099 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.831 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.3 p90 -113.83 150.85 32.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.486 . . . . 75.43 110.91 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.4 t -148.22 123.33 10.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 71.05 110.878 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.568 ' HB3' HG22 ' A' ' 15' ' ' THR . 2.1 m-80 -115.54 85.77 2.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 55.11 110.91 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -15.18 29.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 75.13 110.894 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -71.67 -32.2 67.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 73.02 110.874 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.568 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.9 t -123.94 7.45 8.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 63.24 111.087 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.84 67.18 2.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.736 . . . . 62.15 112.446 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -154.68 115.2 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.877 0.37 . . . . 74.21 110.921 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -137.24 162.09 34.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 54.21 110.856 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 179.02 157.3 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 71.33 110.891 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.553 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -115.48 129.45 56.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 74.3 110.874 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.614 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 70.52 110.881 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.482 -0.247 . . . . 73.33 112.482 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -99.46 -58.19 1.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.982 0.42 . . . . 64.42 110.843 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -94.27 156.89 16.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 72.23 110.912 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.4 mtmm -116.15 79.33 8.48 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.581 0.705 . . . . 74.15 110.851 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -35.02 13.58 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.723 2.282 . . . . 72.42 112.336 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.413 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 15.7 t -134.69 110.55 11.23 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.641 0.734 . . . . 71.13 111.119 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 6' ' ' VAL . 53.9 Cg_endo -69.7 -173.6 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.727 2.284 . . . . 62.43 112.365 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 pt -113.49 123.91 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 51.42 111.109 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.814 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -137.13 136.51 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 70.21 111.138 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.814 ' N ' HD12 ' A' ' 9' ' ' ILE . 2.7 p90 -114.98 150.67 35.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.207 -0.451 . . . . 45.31 110.943 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.8 t -146.28 130.14 17.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 73.1 110.881 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.433 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.6 m-20 -106.47 87.31 2.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 75.52 110.909 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -57.6 -16.52 10.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 73.34 110.857 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -69.74 -30.7 68.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 62.14 110.88 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.433 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.6 t -130.92 8.72 4.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 74.32 111.117 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.32 70.49 0.93 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.744 -0.741 . . . . 35.21 112.5 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -155.21 116.63 4.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 72.32 110.915 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.97 170.91 12.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 51.35 110.851 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.55 156.52 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 72.51 110.9 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.515 ' CG ' ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -106.45 140.68 38.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 74.54 110.868 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.486 ' CE1' ' HD1' ' A' ' 10' ' ' TYR . 3.1 m-85 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 70.42 110.88 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.492 -0.243 . . . . 52.13 112.492 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m -121.39 -54.54 1.98 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.916 0.388 . . . . 61.44 110.854 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -124.66 142.07 51.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 51.32 110.884 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.15 79.32 2.76 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.644 0.735 . . . . 72.51 110.893 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -32.82 18.06 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.738 2.292 . . . . 63.34 112.342 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.71 110.54 11.2 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.676 0.75 . . . . 74.02 111.144 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 179.71 3.5 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.673 2.249 . . . . 72.35 112.376 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.7 pt -113.58 123.34 69.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 52.11 111.089 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.84 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.13 140.01 38.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 75.32 111.142 179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.84 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -113.96 150.82 33.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.892 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.7 t -148.31 123.56 10.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 61.54 110.907 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.567 ' HB3' HG22 ' A' ' 15' ' ' THR . 2.1 m-80 -115.82 85.79 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 75.4 110.867 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 -61.18 -15.05 29.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 71.21 110.862 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -71.79 -32.23 67.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 53.03 110.887 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.567 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.9 t -123.81 7.51 8.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 73.35 111.137 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.74 67.18 2.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 53.04 112.498 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -154.69 115.31 3.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.338 . . . . 75.23 110.9 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.89 162.75 32.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 54.14 110.873 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 178.98 157.87 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 45.12 110.949 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -116.57 129.22 56.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 73.31 110.902 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.6 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 75.44 110.898 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.254 0 N-CA-C 112.499 -0.241 . . . . 72.34 112.499 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.2 p -138.85 -69.46 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 62.33 110.843 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -100.03 171.85 7.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 54.35 110.877 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.14 79.41 3.63 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.552 0.692 . . . . 61.23 110.857 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.86 -32.82 17.43 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.683 2.256 . . . . 74.22 112.332 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.8 110.53 11.11 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.646 0.736 . . . . 75.54 111.103 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -176.55 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.654 2.236 . . . . 73.31 112.317 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.444 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.5 pt -113.64 123.13 68.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 55.41 111.115 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.825 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.67 141.08 35.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 64.21 111.119 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.825 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.6 p90 -114.25 150.09 34.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 50.11 110.925 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 t -149.25 120.65 7.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 62.44 110.878 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.484 ' HB3' HG22 ' A' ' 15' ' ' THR . 31.4 m120 -114.41 88.31 2.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.477 . . . . 73.15 110.851 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -58.58 -17.82 24.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 65.53 110.846 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -76.26 -56.07 4.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 74.35 110.86 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.5 t -92.18 8.93 35.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 73.31 111.161 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.06 68.34 1.45 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.76 -0.733 . . . . 44.25 112.524 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -155.18 116.57 4.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.796 0.331 . . . . 74.02 110.938 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.5 m -136.03 157.06 47.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 54.22 110.846 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.411 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 1.7 tt0 178.36 158.57 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 63.34 110.932 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -117.61 129.52 55.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.12 110.842 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.594 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 75.24 110.933 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.491 -0.244 . . . . 72.43 112.491 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -118.74 -63.59 1.39 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.915 0.388 . . . . 74.43 110.874 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.03 159.31 34.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 74.25 110.872 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.64 79.36 4.27 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.527 0.68 . . . . 70.24 110.888 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -32.83 17.57 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.633 2.222 . . . . 74.3 112.33 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.8 t -134.78 110.57 11.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.691 0.758 . . . . 73.24 111.128 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -173.03 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.648 2.232 . . . . 74.12 112.345 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.5 pt -113.64 123.12 68.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 64.42 111.088 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.835 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.65 141.05 35.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.472 . . . . 72.14 111.135 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.835 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.6 p90 -114.23 150.12 34.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 74.45 110.914 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.3 t -149.32 120.49 7.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 75.2 110.893 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.482 ' HB3' HG22 ' A' ' 15' ' ' THR . 31.2 m120 -114.26 88.26 2.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.44 110.878 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -58.59 -17.8 24.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 72.01 110.859 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -76.15 -55.89 5.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 61.3 110.84 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.482 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.5 t -92.53 8.98 36.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 64.43 111.135 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.12 68.36 1.45 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 62.1 112.468 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -155.29 116.59 3.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 61.11 110.918 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.3 m -136.02 157.13 47.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 65.31 110.867 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.406 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 4.0 tt0 178.38 158.49 0.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 75.5 110.951 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.59 129.51 55.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 75.14 110.894 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.601 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 51.23 110.908 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.498 -0.241 . . . . 71.13 112.498 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.28 -72.04 0.65 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 50.53 110.87 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -91.96 169.65 10.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 71.54 110.92 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -121.8 79.34 40.39 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.561 0.696 . . . . 74.14 110.874 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -33.52 16.41 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.647 2.231 . . . . 64.42 112.338 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.8 t -134.68 110.58 11.25 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.662 0.744 . . . . 72.22 111.105 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 174.32 9.63 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.688 2.259 . . . . 74.23 112.396 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.5 pt -113.63 123.23 69.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.44 . . . . 55.02 111.134 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.842 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -139.56 142.03 33.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 72.34 111.14 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.842 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.5 p90 -113.84 149.8 34.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 72.35 110.887 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.82 116.95 6.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 72.42 110.898 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.42 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.7 m-80 -117.65 86.78 2.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.867 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.0 ptt85 -60.57 -16.05 33.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 74.42 110.9 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -71.97 -56.33 5.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 74.51 110.855 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.42 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.8 t -96.88 10.25 39.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 72.13 111.133 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.79 72.34 0.56 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.736 -0.745 . . . . 70.2 112.502 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -154.37 114.54 3.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.819 0.342 . . . . 42.33 110.868 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.4 t -135.33 152.65 51.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 73.12 110.899 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.42 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 3.2 tt0 175.84 159.51 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 74.24 110.89 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -119.21 129.41 54.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 73.31 110.901 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.594 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 75.44 110.901 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.472 -0.251 . . . . 72.43 112.472 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.15 -66.58 0.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.934 0.397 . . . . 72.11 110.885 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.95 171.3 7.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 73.33 110.911 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -114.02 79.35 4.76 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.585 0.707 . . . . 71.24 110.916 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -32.73 18.19 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.723 2.282 . . . . 73.22 112.358 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.81 110.61 11.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.643 0.735 . . . . 74.53 111.12 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -174.86 1.0 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.726 2.284 . . . . 74.12 112.308 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.4 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.7 pt -113.49 123.33 69.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 75.33 111.153 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.825 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.1 140.2 38.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.462 . . . . 73.2 111.11 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.825 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -114.18 150.81 33.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 73.34 110.952 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.7 t -148.41 125.02 11.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 63.35 110.861 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.465 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.8 m-80 -116.23 87.12 2.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 73.41 110.919 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -15.79 29.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 62.32 110.895 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -44.63 66.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 75.12 110.871 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.465 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.2 t -110.27 8.53 23.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 70.43 111.163 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.79 70.24 1.02 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.737 . . . . 51.22 112.497 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 9.7 ptmt -159.34 119.91 3.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 74.41 110.879 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.58 165.19 27.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 62.23 110.887 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.4 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 1.3 tt0 178.65 157.94 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 73.12 110.93 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.06 129.42 55.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 75.35 110.837 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.595 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 73.45 110.857 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.494 -0.242 . . . . 61.14 112.494 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -131.97 -70.46 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 73.43 110.898 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -138.43 160.03 40.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 74.51 110.892 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -127.82 79.38 73.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.619 0.723 . . . . 65.2 110.902 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -33.68 16.19 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.69 2.26 . . . . 72.22 112.345 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.7 t -134.7 110.57 11.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.601 0.715 . . . . 74.43 111.133 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 173.85 10.37 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.671 2.247 . . . . 75.34 112.35 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.7 pt -113.62 123.33 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 74.14 111.126 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.841 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.07 140.19 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 74.34 111.103 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.841 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -114.21 150.81 33.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 71.23 110.882 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.6 t -148.33 125.0 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 52.12 110.913 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.478 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.8 m-80 -116.3 87.14 2.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 73.31 110.859 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -60.49 -15.71 29.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 73.14 110.881 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -70.6 -44.22 67.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 75.2 110.862 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.478 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.2 t -110.76 8.42 22.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 75.21 111.143 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.94 70.12 1.06 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.772 -0.727 . . . . 74.4 112.487 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 12.1 ptmt -159.25 119.87 3.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 74.2 110.909 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.59 165.23 27.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 73.21 110.86 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 178.63 157.96 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 53.34 110.923 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.06 129.45 56.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 74.33 110.891 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.604 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.859 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.492 -0.243 . . . . 75.12 112.492 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.57 -50.66 0.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.903 0.382 . . . . 72.42 110.839 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.5 pttt -127.89 156.84 41.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 72.43 110.935 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.93 79.34 2.6 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.529 0.68 . . . . 71.4 110.882 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -32.58 18.05 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.673 2.249 . . . . 53.32 112.338 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.77 110.55 11.15 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.63 0.728 . . . . 73.41 111.13 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -171.64 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.7 2.267 . . . . 34.13 112.323 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.414 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.6 pt -113.57 123.28 69.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 74.34 111.151 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.13 140.27 38.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 72.32 111.147 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.838 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -114.2 150.76 33.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 72.11 110.909 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.7 t -148.4 124.98 11.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 73.31 110.894 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.467 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.8 m-80 -116.35 87.06 2.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 63.54 110.882 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.34 -15.85 29.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 75.53 110.856 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.5 -45.21 66.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 71.4 110.836 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.1 t -109.63 8.39 24.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 61.44 111.098 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.9 71.02 0.79 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.798 -0.715 . . . . 35.32 112.476 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 42.0 pttt -160.29 120.21 2.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 52.41 110.878 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.76 165.1 27.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 43.45 110.868 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 178.76 158.04 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 63.45 110.905 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.13 129.39 55.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 73.44 110.877 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.594 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.931 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.472 -0.251 . . . . 53.52 112.472 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.71 -56.25 1.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.982 0.42 . . . . 60.41 110.853 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -134.28 153.64 51.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 73.31 110.903 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -113.47 79.34 4.03 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.553 0.692 . . . . 71.54 110.89 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -32.48 18.43 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.693 2.262 . . . . 35.53 112.303 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.67 110.58 11.25 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.608 0.718 . . . . 61.32 111.109 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -172.17 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.681 2.254 . . . . 72.3 112.317 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.417 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.6 pt -113.57 123.32 69.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 54.13 111.113 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.824 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.11 140.28 38.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 75.04 111.15 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.824 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -114.2 150.8 33.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 65.14 110.923 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.5 t -148.41 124.5 10.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 72.14 110.889 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.464 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.8 m-80 -115.95 86.95 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 60.32 110.87 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -60.47 -15.81 30.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 75.1 110.821 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -70.41 -44.09 68.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 74.13 110.854 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.464 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.1 t -110.77 8.23 22.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 74.52 111.151 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.21 70.72 0.88 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.698 -0.763 . . . . 72.11 112.519 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 8.4 pttp -160.12 120.14 2.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.82 0.343 . . . . 70.22 110.932 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.75 165.16 27.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 73.04 110.824 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.401 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 4.2 tt0 178.76 157.95 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 74.33 110.892 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.02 129.43 56.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 74.41 110.89 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.591 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.453 . . . . 64.22 110.899 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.52 -0.232 . . . . 64.23 112.52 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.27 -64.67 1.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.945 0.403 . . . . 75.34 110.851 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.0 mttt -116.82 160.17 21.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 71.12 110.924 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.67 79.38 16.25 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.562 0.696 . . . . 44.11 110.895 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -32.49 18.4 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.73 2.287 . . . . 73.34 112.331 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.74 110.56 11.17 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.645 0.736 . . . . 74.43 111.126 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -171.16 0.45 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.656 2.238 . . . . 62.25 112.346 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.7 pt -113.6 123.39 69.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 70.43 111.115 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -138.89 139.62 40.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 71.21 111.126 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.838 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.3 p90 -113.97 150.88 33.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 63.43 110.906 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.2 t -148.32 123.76 10.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 74.42 110.909 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.475 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.7 m-80 -115.15 87.07 2.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 72.31 110.896 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -60.38 -15.76 29.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 72.21 110.871 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -70.49 -43.79 69.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 72.54 110.893 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.475 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.3 t -111.14 8.23 21.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 70.35 111.171 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.13 70.59 0.91 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.76 . . . . 74.52 112.481 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -159.74 119.74 2.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 73.34 110.882 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -138.98 164.16 30.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 72.45 110.909 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 178.69 157.32 0.48 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 74.2 110.903 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.549 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -115.6 129.57 56.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.52 110.858 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.595 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.14 110.898 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.54 -0.224 . . . . 65.13 112.54 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -130.6 -68.49 0.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.895 0.379 . . . . 54.11 110.883 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -130.8 171.1 13.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 54.24 110.91 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -111.99 79.33 2.64 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.58 0.705 . . . . 65.13 110.905 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -33.52 16.38 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.683 2.255 . . . . 55.5 112.356 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.7 t -134.76 110.55 11.15 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.72 . . . . 73.12 111.103 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -174.63 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.704 2.269 . . . . 74.22 112.375 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.446 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.5 pt -113.54 123.06 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 41.23 111.159 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.73 141.11 35.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 71.5 111.133 179.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.838 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.6 p90 -114.24 150.08 34.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 73.41 110.91 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.1 t -149.35 120.48 7.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 60.1 110.899 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.472 ' HB3' HG22 ' A' ' 15' ' ' THR . 30.6 m120 -114.48 88.37 2.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 73.34 110.917 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -58.63 -17.81 25.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 64.41 110.835 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.06 -56.18 4.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 74.35 110.895 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.472 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.5 t -92.15 8.86 36.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 43.34 111.128 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.17 68.44 1.42 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.768 -0.729 . . . . 63.23 112.455 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.6 mtpp -155.26 116.56 3.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.809 0.338 . . . . 64.34 110.855 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.9 m -136.11 157.01 47.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 70.21 110.861 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.404 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 2.1 tt0 178.29 158.54 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 55.51 110.948 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.508 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -117.6 129.53 55.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 54.43 110.869 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.598 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 65.32 110.869 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.446 -0.262 . . . . 72.53 112.446 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.0 t -105.19 -65.92 1.01 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.899 0.38 . . . . 43.12 110.817 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.49 162.41 13.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 62.11 110.892 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.0 mttp -127.63 79.35 73.61 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.608 0.718 . . . . 75.22 110.917 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -38.49 7.72 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.719 2.279 . . . . 75.34 112.314 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.406 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 15.7 t -134.73 110.61 11.19 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.595 0.712 . . . . 63.03 111.104 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 6' ' ' VAL . 53.9 Cg_endo -69.77 -170.96 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.703 2.268 . . . . 53.54 112.328 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 pt -113.45 123.83 69.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 74.33 111.139 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.818 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -137.11 135.85 47.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 55.25 111.116 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.818 ' N ' HD12 ' A' ' 9' ' ' ILE . 2.8 p90 -115.14 150.83 35.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 63.42 110.95 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.0 t -145.12 133.9 22.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 50.02 110.888 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.469 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.5 m-20 -107.99 88.15 2.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 63.43 110.875 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.5 mtt180 -57.73 -16.46 11.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 75.53 110.878 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.9 mmt-85 -70.46 -31.01 67.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 72.21 110.874 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.469 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.0 t -129.35 8.47 5.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 63.21 111.137 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.47 74.81 0.27 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.719 -0.753 . . . . 33.42 112.516 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.416 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 3.3 pttt -162.22 120.9 2.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 74.04 110.905 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.95 170.99 12.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 62.52 110.902 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -176.66 154.84 1.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 60.01 110.952 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.509 ' CG ' ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -105.34 140.79 37.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 71.25 110.908 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.493 ' CE1' ' HD2' ' A' ' 10' ' ' TYR . 3.4 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 65.02 110.883 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.452 -0.259 . . . . 65.44 112.452 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -121.74 -65.0 1.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.946 0.403 . . . . 72.23 110.879 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -98.06 173.54 6.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 75.24 110.867 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -112.3 79.39 2.9 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.639 0.733 . . . . 74.41 110.916 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -32.58 18.39 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.696 2.264 . . . . 74.11 112.36 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.5 t -134.71 110.56 11.21 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.643 0.735 . . . . 41.44 111.14 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -174.94 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.689 2.26 . . . . 74.14 112.317 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.406 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.7 pt -113.62 123.13 68.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 74.21 111.131 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.829 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.37 140.7 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.11 111.134 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.829 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.6 p90 -114.36 150.41 34.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 74.52 110.898 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.7 t -149.25 123.66 9.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.101 -0.5 . . . . 73.4 110.879 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.528 ' HB3' HG22 ' A' ' 15' ' ' THR . 33.7 m120 -113.57 88.82 2.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 71.32 110.884 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.8 mmm-85 -58.55 -17.72 23.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 74.31 110.896 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.27 -56.92 4.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 73.34 110.857 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.528 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.3 t -90.14 7.85 35.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 71.3 111.18 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.94 73.55 0.35 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.736 -0.745 . . . . 62.23 112.474 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.418 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -166.26 123.54 1.38 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.845 0.355 . . . . 74.55 110.882 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 m -139.19 165.26 27.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 44.1 110.885 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.402 ' CG ' ' N ' ' A' ' 20' ' ' ARG . 1.7 tt0 178.28 158.2 0.47 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 74.1 110.894 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -117.8 129.74 55.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 73.32 110.856 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.591 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 72.25 110.872 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.481 -0.248 . . . . 61.25 112.481 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.3 t -122.65 -69.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.927 0.394 . . . . 72.42 110.844 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -109.02 158.72 17.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.107 -0.497 . . . . 55.04 110.903 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -125.43 79.32 67.04 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.584 0.707 . . . . 74.14 110.898 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -33.11 17.23 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.721 2.281 . . . . 70.02 112.316 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.7 t -134.77 110.58 11.14 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.59 0.709 . . . . 42.12 111.14 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -178.2 2.24 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.63 2.22 . . . . 75.22 112.332 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.41 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.6 pt -113.59 123.16 68.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 74.0 111.121 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.847 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.42 140.71 36.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 65.15 111.121 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.847 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.6 p90 -114.48 150.39 34.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 71.42 110.921 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.4 t -149.2 123.94 9.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 73.24 110.877 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.529 ' HB3' HG22 ' A' ' 15' ' ' THR . 33.7 m120 -113.57 88.85 2.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 72.41 110.875 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -58.53 -17.74 23.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 54.44 110.845 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.9 mtt180 -76.22 -56.79 4.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 74.44 110.872 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.529 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.3 t -90.33 7.93 36.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.156 -0.475 . . . . 72.34 111.126 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 49.8 73.31 0.37 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.759 -0.734 . . . . 65.42 112.524 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 43.6 pttt -166.18 123.46 1.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 63.31 110.883 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.6 m -139.09 165.74 26.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 64.31 110.927 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 178.27 158.17 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 72.25 110.883 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -117.7 129.65 55.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 75.41 110.842 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.602 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 74.4 110.926 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.495 -0.242 . . . . 75.21 112.495 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.38 -71.91 0.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.97 0.414 . . . . 51.32 110.857 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.61 159.98 15.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 53.31 110.893 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.39 79.31 2.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.603 0.716 . . . . 74.14 110.873 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -34.46 14.62 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.709 2.272 . . . . 75.14 112.316 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.6 t -134.65 110.55 11.26 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.637 0.732 . . . . 71.21 111.117 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 179.39 3.69 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.699 2.266 . . . . 74.24 112.342 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.3 pt -113.65 123.24 69.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 75.51 111.164 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.835 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -139.63 142.17 33.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 64.21 111.125 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.835 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -113.68 149.58 34.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.485 . . . . 71.53 110.897 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.91 116.99 6.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 70.53 110.896 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.415 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.5 m-80 -116.83 86.32 2.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 73.4 110.878 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.4 ptt85 -60.61 -16.13 35.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 72.23 110.865 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -53.72 13.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 74.33 110.865 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.415 HG22 ' HB3' ' A' ' 12' ' ' ASN . 3.6 t -100.22 10.0 41.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.449 . . . . 72.3 111.129 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.56 72.46 0.55 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.749 -0.738 . . . . 44.34 112.517 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -154.38 114.35 3.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.814 0.34 . . . . 73.4 110.935 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.9 t -134.1 153.66 51.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 75.43 110.887 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 176.09 157.22 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 71.51 110.917 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -118.25 128.94 55.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 74.23 110.907 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.594 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 64.31 110.847 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.478 -0.249 . . . . 53.43 112.478 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.53 -59.41 1.8 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.969 0.414 . . . . 54.42 110.891 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.9 pttt -108.32 147.77 31.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.509 . . . . 64.33 110.875 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -131.26 79.34 70.55 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.532 0.682 . . . . 60.45 110.853 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -47.24 0.96 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.683 2.255 . . . . 71.42 112.361 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.59 ' O ' HG13 ' A' ' 6' ' ' VAL . 9.3 p -100.56 110.25 59.79 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.61 0.719 . . . . 72.23 111.101 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 -178.76 2.53 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.657 2.238 . . . . 70.21 112.322 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.8 pt -113.4 124.0 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 71.24 111.148 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.836 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -137.39 136.92 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 74.54 111.101 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.836 ' N ' HD12 ' A' ' 9' ' ' ILE . 2.7 p90 -115.24 150.67 35.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 71.31 110.924 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.6 t -146.37 130.27 17.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 70.52 110.87 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.443 ' HB3' HG22 ' A' ' 15' ' ' THR . 1.6 m-20 -106.76 87.27 2.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 53.32 110.866 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.67 -16.43 10.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 71.33 110.867 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -69.85 -30.71 68.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 71.21 110.861 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.443 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.6 t -130.85 8.73 4.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 72.44 111.126 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.36 70.51 0.93 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.779 -0.724 . . . . 65.14 112.462 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.5 mttm -155.21 116.61 4.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.797 0.332 . . . . 53.22 110.839 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.02 171.08 12.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 54.45 110.895 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -179.54 156.55 0.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 73.01 110.905 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.516 ' CG ' ' HB ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -106.63 140.5 39.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 75.14 110.898 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.496 ' CE1' ' HD2' ' A' ' 10' ' ' TYR . 3.1 m-85 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.45 110.913 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.503 -0.239 . . . . 75.11 112.503 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.63 -67.3 0.76 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.964 0.412 . . . . 71.52 110.867 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.88 156.26 17.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.506 . . . . 72.44 110.868 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -121.8 79.37 40.35 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.537 0.684 . . . . 73.11 110.885 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -43.93 2.39 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.714 2.276 . . . . 43.33 112.328 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.586 ' O ' HG13 ' A' ' 6' ' ' VAL . 9.3 p -100.5 110.21 59.57 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.629 0.728 . . . . 64.24 111.172 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 178.39 4.63 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.715 2.277 . . . . 45.03 112.324 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.402 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.8 pt -113.55 123.33 69.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 74.41 111.155 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.828 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.04 140.01 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.457 . . . . 65.44 111.091 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.828 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -114.0 150.77 33.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 74.14 110.877 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.7 t -148.27 123.61 10.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 73.42 110.914 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.563 ' HB3' HG22 ' A' ' 15' ' ' THR . 2.2 m-80 -115.9 85.71 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.11 110.913 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -61.14 -15.08 29.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 74.33 110.89 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.69 -32.29 67.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 54.35 110.855 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.563 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.9 t -123.86 7.54 8.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.463 . . . . 74.21 111.131 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.79 67.19 2.35 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.762 -0.732 . . . . 72.14 112.511 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -154.64 115.33 3.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.347 . . . . 65.42 110.885 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.7 m -136.83 162.69 32.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 60.35 110.848 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 178.87 157.8 0.52 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 64.43 110.946 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -116.61 129.24 56.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 75.23 110.881 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.608 ' HD1' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 73.32 110.901 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.464 -0.255 . . . . 72.44 112.464 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.24 -59.3 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.971 0.415 . . . . 75.34 110.909 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -132.88 130.64 39.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 73.42 110.866 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.2 79.35 6.46 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.57 0.7 . . . . 65.12 110.855 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -43.64 2.55 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.626 2.217 . . . . 73.32 112.36 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.588 ' O ' HG13 ' A' ' 6' ' ' VAL . 9.3 p -100.52 110.22 59.62 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.644 0.735 . . . . 74.14 111.154 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -178.34 2.31 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.698 2.266 . . . . 65.41 112.354 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.411 HD12 ' HB2' ' A' ' 21' ' ' PHE . 1.6 pt -113.61 123.36 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 60.44 111.109 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.839 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.06 140.0 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 61.41 111.168 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.839 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -113.95 150.79 33.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 54.11 110.959 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.8 t -148.31 123.94 10.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 72.51 110.872 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.569 ' HB3' HG22 ' A' ' 15' ' ' THR . 2.2 m-80 -116.2 85.84 2.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 64.42 110.862 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -61.16 -15.06 29.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 72.13 110.914 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 5.2 mmm-85 -71.81 -32.25 67.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 74.11 110.869 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.569 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.9 t -123.85 7.48 8.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 65.51 111.079 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.77 67.09 2.4 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 72.33 112.506 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -154.61 115.36 3.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.819 0.342 . . . . 74.45 110.9 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.96 162.81 32.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 73.31 110.88 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 178.88 157.83 0.52 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 65.23 110.905 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -116.59 129.23 56.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 72.4 110.917 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.607 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 73.31 110.895 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.479 -0.248 . . . . 71.13 112.479 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 t -127.94 -53.61 1.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.977 0.418 . . . . 74.42 110.847 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.97 144.45 35.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 71.33 110.878 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -116.35 79.42 8.99 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.583 0.706 . . . . 73.12 110.894 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -47.45 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.678 2.252 . . . . 73.2 112.342 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 6' ' ' VAL . 9.3 p -100.57 110.19 59.61 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.581 0.705 . . . . 62.31 111.157 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -177.25 1.79 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.655 2.236 . . . . 75.4 112.374 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.55 123.33 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 61.24 111.117 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -139.08 139.89 39.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 62.13 111.146 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.838 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 p90 -113.95 150.77 33.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 75.43 110.867 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.9 t -148.2 123.59 10.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 61.24 110.873 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.555 ' HB3' HG22 ' A' ' 15' ' ' THR . 2.1 m-80 -115.67 85.74 2.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 64.44 110.871 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -15.09 29.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 61.05 110.845 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -71.76 -32.21 67.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 63.4 110.872 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.555 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.9 t -123.93 7.56 8.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 70.04 111.096 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.74 67.2 2.34 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 24.14 112.489 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -154.77 115.37 3.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.369 . . . . 71.43 110.887 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.85 163.0 31.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 61.41 110.9 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 178.85 157.79 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 53.33 110.924 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.3 OUTLIER -116.55 129.22 56.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 72.22 110.871 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.606 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 73.24 110.856 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.488 -0.245 . . . . 61.15 112.488 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -135.22 -69.08 0.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.866 0.365 . . . . 72.51 110.875 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.95 161.55 28.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 75.35 110.933 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.1 mttt -117.71 79.28 12.75 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.575 0.703 . . . . 74.21 110.935 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -45.82 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.703 2.269 . . . . 71.54 112.363 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 6' ' ' VAL . 9.3 p -100.58 110.21 59.72 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.65 0.738 . . . . 72.33 111.101 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 6' ' ' VAL . 54.3 Cg_endo -69.74 169.41 18.95 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.682 2.255 . . . . 71.24 112.4 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.9 pt -113.55 123.4 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 74.11 111.161 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.831 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -138.99 139.52 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 73.43 111.099 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.831 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.3 p90 -113.83 150.85 32.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.486 . . . . 75.43 110.91 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.4 t -148.22 123.33 10.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 71.05 110.878 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.568 ' HB3' HG22 ' A' ' 15' ' ' THR . 2.1 m-80 -115.54 85.77 2.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 55.11 110.91 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -15.18 29.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 75.13 110.894 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -71.67 -32.2 67.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 73.02 110.874 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.568 HG22 ' HB3' ' A' ' 12' ' ' ASN . 4.9 t -123.94 7.45 8.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 63.24 111.087 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.84 67.18 2.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.736 . . . . 62.15 112.446 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -154.68 115.2 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.877 0.37 . . . . 74.21 110.921 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -137.24 162.09 34.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 54.21 110.856 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 179.02 157.3 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 71.33 110.891 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.553 ' HA ' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -115.48 129.45 56.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 74.3 110.874 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.614 ' HD2' ' N ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 70.52 110.881 -179.958 . . . . . . . . 2 2 . 1 stop_ save_